KR101827775B1 - Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients - Google Patents
Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients Download PDFInfo
- Publication number
- KR101827775B1 KR101827775B1 KR1020160046678A KR20160046678A KR101827775B1 KR 101827775 B1 KR101827775 B1 KR 101827775B1 KR 1020160046678 A KR1020160046678 A KR 1020160046678A KR 20160046678 A KR20160046678 A KR 20160046678A KR 101827775 B1 KR101827775 B1 KR 101827775B1
- Authority
- KR
- South Korea
- Prior art keywords
- collagen
- eyebrows
- eyebrow
- food
- enzyme food
- Prior art date
Links
- 210000004709 eyebrow Anatomy 0.000 title claims abstract description 199
- 235000013305 food Nutrition 0.000 title claims abstract description 134
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 132
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 132
- 102000008186 Collagen Human genes 0.000 title claims abstract description 122
- 108010035532 Collagen Proteins 0.000 title claims abstract description 122
- 229920001436 collagen Polymers 0.000 title claims abstract description 122
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000004480 active ingredient Substances 0.000 title claims abstract description 20
- 210000000282 nail Anatomy 0.000 title description 50
- 210000004906 toe nail Anatomy 0.000 title 1
- 230000003779 hair growth Effects 0.000 claims abstract description 15
- 210000004209 hair Anatomy 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 16
- 244000068988 Glycine max Species 0.000 claims description 14
- 235000010469 Glycine max Nutrition 0.000 claims description 14
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 201000004384 Alopecia Diseases 0.000 claims description 9
- 230000003676 hair loss Effects 0.000 claims description 8
- 208000024963 hair loss Diseases 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 2
- 235000010716 Vigna mungo Nutrition 0.000 claims 4
- 240000001417 Vigna umbellata Species 0.000 claims 4
- 235000011453 Vigna umbellata Nutrition 0.000 claims 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000209094 Oryza Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 52
- 230000001965 increasing effect Effects 0.000 abstract description 34
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 11
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 230000001079 digestive effect Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 description 20
- 230000008859 change Effects 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 17
- 230000007423 decrease Effects 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 240000007594 Oryza sativa Species 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 12
- 229960000907 methylthioninium chloride Drugs 0.000 description 12
- 230000003247 decreasing effect Effects 0.000 description 11
- 230000037406 food intake Effects 0.000 description 11
- 235000013376 functional food Nutrition 0.000 description 11
- 235000013339 cereals Nutrition 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 208000017657 Menopausal disease Diseases 0.000 description 9
- 230000032683 aging Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 244000063299 Bacillus subtilis Species 0.000 description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 235000001916 dieting Nutrition 0.000 description 6
- 230000037228 dieting effect Effects 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000002075 main ingredient Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 206010027304 Menopausal symptoms Diseases 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000720 eyelash Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 208000026721 nail disease Diseases 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- -1 olive oil Chemical compound 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GICIECWTEWJCRE-UHFFFAOYSA-N 3,4,4,7-tetramethyl-2,3-dihydro-1h-naphthalene Chemical compound CC1=CC=C2C(C)(C)C(C)CCC2=C1 GICIECWTEWJCRE-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241000123815 Lutjanus apodus Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000997826 Melanocetus johnsonii Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000003646 hair health Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 238000011059 hazard and critical control points analysis Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036072 healthy nails Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003101 melanogenic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 효소 식품(enzyme food) 및 콜라겐(collagen)을 유효성분을 함유하는 갱년기 여성 눈썹 육모 및 손톱 개선용 조성물에 관한 것으로, 구체적으로 본 발명의 효소 식품 및 콜라겐은 노화로 인해 떨어지는 소화 흡수력을 개선시키고, 체내 단백질 농도를 증가시켜 유의적인 눈썹 육모 효과 및 손톱 강화 효과를 나타내며, 특히 효소 식품 단독 및 콜라겐 단독 처리군과 비교하여 현저한 상승효과(synergy effect)를 나타내므로, 갱년기 여성을 위한 눈썹 육모용 조성물 또는 손톱 강화용 조성물의 유효성분으로 유용하게 사용될 수 있다.The present invention relates to a composition for improving the appearance of eyebrows and nails of menopausal women, which contains an active ingredient of enzyme food and collagen. More particularly, the enzyme food and collagen of the present invention are used for reducing the digestive absorption ability And exhibits significant eyebrow hair growth effect and nail strengthening effect by increasing body protein concentration. In particular, since it exhibits a synergistic effect compared with enzyme food alone and collagen alone treatment group, eyebrow hair growth for menopausal women The composition of the present invention can be effectively used as an active ingredient of a composition for nail or a composition for nail strengthening.
Description
본 발명은 효소 식품(enzyme food) 및 콜라겐(collagen) 복합물을 유효성분으로 함유하는 갱년기 여성 눈썹 육모용 조성물 및 갱년기 여성 손톱 개선용 약학적 조성물, 및 건강기능식품에 관한 것이다.
The present invention relates to a composition for menopausal climacteric menopausal women comprising an enzyme food and a collagen complex as an active ingredient, a pharmaceutical composition for improving menopausal female nails, and a health functional food.
눈썹은 사람의 인상을 결정짓는 중요한 요소 중 하나로 인식되고 있다. 많은 여성들이 가지런하고 자신에게 어울리는 예쁜 눈썹을 그리기 위해 많은 시간을 투자하거나 눈썹 문신을 하기도 한다. 하지만, 눈썹이 거의 없는 부위에 문신을 하면 인위적인 느낌이 들뿐만 아니라 눈썹의 형태가 시대와 유행에 따라 변하기 때문에 위험부담이 크다(김영삼, 2015).Eyebrows are recognized as one of the important factors that determine human impressions. Many women are investing a lot of time or drawing eyebrow tattoos to draw beautiful eyebrows that are suitable for them. However, if tattoos are applied to areas where there is little eyebrows, it is not only an artifact, but also the shape of eyebrows changes with age and fashion, which is a great risk (Kim Young-sam, 2015).
글로벌 색조화장품 브랜드인 메이블린 뉴욕이 지난해 12월 소셜 네트워크서비스(SNS)를 통해 한국 여성 3,400명을 대상으로 시행한 ‘눈썹 고민’을 조사한 결과, 대상자 중 42%가 눈썹 숱이 적거나 퍼져있어 고민이라고 응답했다(중앙일보-2015. 2. 4). 눈썹은 개개인마다 모양이나 짙음 정도 등이 달라 눈썹 숱이 적거나 부분적으로 눈썹이 없을 경우, 콤플렉스의 요인이 되며(조소영, 이정민, 2011), 대인관계에서 유약해 보이고, 매력적인 인상을 주기 어렵다(Gandelman, 1995). 이처럼 눈썹은 사람의 인상을 좌우하여 외적 이미지에 큰 영향을 미치므로, 그 중요성이 강조된다.
Maybelline New York, a global cosmetics brand, surveyed 3,400 Korean women through Social Network Service (SNS) last December, and found that 42% of the respondents said that their eyebrows were thin or spread. (Joongang Ilbo-Feb. 20, 2014). The eyebrows are different from each other in shape and depth, and when the eyebrows are thin or the eyebrows are partially absent, it becomes a factor of the complex (Joo Soo-young, Lee Jeong-min, 2011) , 1995). Thus, the importance of the eyebrows is emphasized because it affects the external image by influencing the impression of the person.
김영삼(2015)의 연구에 따르면 눈썹 숱이 적어지는 가장 큰 요인이 노화인 것으로 인식되고 있음을 알 수 있다. 40대 이후 중년 여성의 경우에 노화현상과 더불어 인체 호르몬의 변화가 발생하는 시기로 에스트로겐은 감소되고 난포자극호르몬과 황체호르몬의 증가, 부신피질 호르몬의 감소로 호르몬계에 혼란이 오고 갱년기 증상이 유발된다(안지영 등, 2006; Healing hair care institute. 2002). 이로 인해 체력이 감소되어 쉽게 피로를 느끼고, 피로 회복의 시간도 점차 길어진다. 또한, 머리카락과 치아가 빠지고 위액분비가 줄고, 위벽은 위축되기 시작하여 장의 소화 효소 분비 감소로 영양분의 흡수력이 저하되며, 췌장의 활동도 감소된다. 또 지방 및 단백질분해가 저하되고 지방의 흡수와 소화력 또한 떨어진다(이묘숙, 2012; Arene & Irene, 1993). 노화로 인해 신체세포가 노화되고 파괴되어 세포수가 감소하고, 장기의 위축과 기능저하가 진행되는데, 소화기 장기도 예외는 아니어서 노인이 되면 장기가 위축되고 기능이 저하된다(Holt, 1991; Russell, 1992). 따라서 40대부터 약화되기 시작한 소화기능은 위액이 감소하면서 단백질 소화능력이 감퇴되어(김미옥, 1987), 신진대사 기능이 떨어지고 소화효소액도 줄어들기 시작한다.
According to a study by Kim Young-sam (2015), it can be seen that the biggest factor in reducing eyebrows is recognized as aging. In the case of middle-aged women in their 40s or older, when estrogen changes with the aging phenomenon, estrogen is decreased, the increase of follicle stimulating hormone and progesterone, decrease of adrenocortical hormone causes confusion in the hormonal system and causes menopausal symptoms (Ahn JY, et al., 2006; Healing hair care institute, 2002). As a result, the physical strength is reduced and the fatigue is easily felt. In addition, hair and teeth are removed, gastric juice secretion is reduced, gastric wall begins to be contracted, and the digestive enzyme secretion of the intestine is reduced, resulting in decreased absorption of nutrients and decreased activity of the pancreas. In addition, fat and protein degradation are reduced and fat absorption and digestibility are also impaired (Lee et al., 2012; Arene & Irene, 1993). In this study, we investigated the effects of aging on the number of cells in the body, the number of cells in the body, the number of cells in the body, 1992). Therefore, the digestive function, which began to weaken from the forties, decreased protein digestion ability as the gastric juice decreased (Kim Mi-ok, 1987), and the metabolic function was lowered and the digestive enzyme volume started to decrease.
또한, 노화 또는 갱년기로 인한 손톱의 변화는 손톱판(nail plate)이 점점 더 볼록해지며, 측면으로부터 조여들고, 황색으로의 변색 등이 있으며(대한피부과학회 교과서 편찬위원회, 2008), 면역 저하로 인한 진균의 감염은 손톱의 성장 속도가 저하된 고령층에서 발생 빈도가 높아지고(김정 등, 1983; Roberts, 1992), 조갑진균증은 가장 흔한 조갑 질환으로 전체 손톱 질환의 50% 정도를 차지할 정도로 흔히 관찰된다(김종순, 1992; Scher, 1994). Orentreich(1979) 등은 성장속도의 감소는 구체적으로 25세부터 해마다 조갑의 성장 속도가 0.5% 정도씩 감소한다고 하였고, Bean(1974)은 30년간 자신의 손톱 성장속도를 측정한 결과 연령적으로 30대에서는 1일 0.123mm 성장한데 비하여 60대에 와서는 0.100mm로 성장이 줄어들었다고 보고하였다.
In addition, changes in the nail caused by aging or menopausal periods are more and more convex on the nail plate, tightened from the side and discolored to yellow (Korean Dermatological Association Textbook Compilation Committee, 2008) Infectious fungal infections are more common in older adults with reduced nail growth rates (Kim et al., 1983; Roberts, 1992), and nail fungus is the most common nail disease, accounting for 50% of all nail diseases (Kim, JS, 1992; Scher, 1994). Orentreich et al. (1979) reported that the rate of growth of the nail decreased by 0.5% each year from the age of 25, and Bean (1974) And 0.123mm in 1 day, compared to 0.100mm in 60s.
Enzyme이라고 불리는 효소는 그리스어 “효모의 속”이라는 뜻에서 유래되었다. 효소는 단백질로 구성되어 있으며, 생물체 내에서 합성되고 각종 화학반응에서 자신은 변하지 않으나 반응속도를 빠르게 하는 특성을 가지고 있다. 일반적으로 생체 내에서 만들어져 생체에서 일어나는 온갖 반응의 촉매작용을 하는 유기화합물의 총칭이라 할 수 있다(김일천, 1993). '효소 식품'이란 식용 미생물을 배양한 것 또는 배아, 과일, 채소, 곡류 등에서 효소함유 부분을 추출한 것 또는 이를 주원료로 하여 먹기 좋도록 여러 형태로 가공한 제품으로써, 건강기능식품의 하나로 분류되고 있다(한국식품과학회, 2006). 효소 식품은 효소의 활성을 유지하면서 식품의 소화 흡수율을 증대시킬 수 있도록 도와준다(김일천, 1993; 이은주와 이철호, 2001). 생명현상을 유지하는데 아주 중요한 역할을 하는 이 효소는 사람이 나이가 들면서 세포가 노화되고 장기의 기능이 저하되어 효소의 분비량이 떨어져 전체적인 활성이 감소된다. 따라서 중년 이후부터는 대부분 소화력이 점점 감퇴하게 되는 것이다(황지영, 2015).
The enzyme called Enzyme comes from the Greek word "genus of yeast". Enzymes are composed of proteins. They are synthesized in living organisms and have the property of accelerating the reaction without changing themselves in various chemical reactions. Generally, it is a generic name of organic compounds that are produced in vivo and catalyze all kinds of reactions occurring in living organisms (Kim, Cheon, 1993). "Enzyme food" means a product obtained by cultivating an edible microorganism or extracting an enzyme-containing portion from an embryo, fruit, vegetable, or cereal, or by processing it into various forms so as to be eaten as a main ingredient, and is classified as one of health functional foods (Korean Food Science Society, 2006). Enzyme foods help to increase digestion and absorption rate of food while maintaining enzyme activity (Kim, Cheol, 1993; Lee, Eun and Lee, 2001). This enzyme, which plays an important role in maintaining the life phenomenon, ages the cells as the person gets older and the function of the organs declines and the enzyme activity decreases and the overall activity decreases. Therefore, the digestive power is gradually decreasing from the middle age (Hwang Ji-young, 2015).
콜라겐(collagen)은 체내 단백질의 약 20~30%를 차지하고 있으며, 거의 모든 체내기관을 구성하고 있는 구성단백질로(Swatschek et al., 2002) 골격을 형성하고, 피부, 연골, 조직, 힘줄 등의 주요한 성분을 이루는 섬유 단백질이다(함미영, 2007). 콜라겐은 세포의 재생 촉진과 면역 기능의 향상, 신진대사 활성화, 보습력 유지 등에 효과가 있으며, 관절을 튼튼하게 해주고(Koch & Chedekel, 1987), 인간의 성장호르몬(human growth hormone)생산을 자극하여 체중 감량 등의 기능을 한다(Zague, 2008). Collagen is a constituent protein that constitutes almost 20 to 30% of body proteins and constitutes almost all of the body's organs (Swatschek et al., 2002). It forms the skeleton, and the skin, cartilage, It is a fiber protein that constitutes a major component (Hammyoung, 2007). Collagen is effective in promoting cell regeneration, improving immune function, activating metabolism, maintaining moisturizing power, strengthening joints (Koch & Chedekel, 1987), stimulating the production of human growth hormone Weight loss, etc. (Zague, 2008).
다만, 상기와 같은 효소, 효소식품 또는 콜라겐의 효능이 다수 알려져 있으나, 효소 식품 및 콜라겐 복합식이의 갱년기 여성의 현저한 눈썹 육모 및 손톱 개선 효과에 대해서는 알려진바 없다.
However, many of the above-mentioned enzymes, enzyme foods, or collagen have been known to be effective. However, the effect of improving the eyebrows and nails of the menopausal women of the enzyme food and the collagen complex is not known.
이에, 본 발명자들은 중년여성을 위한 눈썹 육모 및 손톱 개선 효과를 갖는 조성물을 개발하기 위해 노력한 결과, 영양보충요법의 간접적인 방법으로 중년여성들의 감퇴한 소화력에 도움을 줄 수 있는 효소 식품과 단백질의 영양과 흡수 증진에 도움을 주는 콜라겐을 각각 단독 섭취하는 그룹과 효소 식품과 콜라겐을 복합 섭취하는 그룹을 비교 분석하였으며, 복합섭취로 인한 영양분의 소화흡수가 더욱 증진되고 개선될 수 있고, 이로 인해 중년여성의 눈썹 육모 및 손톱개선에 유의적인 효과를 나타냄을 확인함으로써, 상기 효소 식품 및 콜라겐 복합물을 갱년기 여성에 대한 눈썹 육모 및 손톱개선용 조성물로 유용하게 사용될 수 있음을 밝힘으로써, 본 발명을 완성하였다.
Accordingly, the present inventors have made efforts to develop a composition having eyebrow hair and nail improving effect for middle-aged women, and as a result, it has been found that an indirect method of nutritional supplement therapy, This study was conducted to compare the intake of collagen and collagen, which are supplemented with collagen and enzyme food, in order to enhance nutrition absorption and digestion. The present inventors have completed the present invention by confirming that the enzyme food and the collagen complex can be effectively used as a composition for eyebrow hair formation and nail improvement for menopausal women .
본 발명의 목적은 효소 식품(enzyme food) 및 콜라겐(collagen)을 유효성분으로 함유하는 갱년기 질환 예방 및 치료용 조성물을 제공하기 위한 것이다.
An object of the present invention is to provide a composition for the prevention and treatment of menopausal disease which contains an enzyme food and collagen as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 효소 식품(enzyme food) 및 콜라겐(collagen)을 유효성분으로 함유하는 갱년기 질환 예방 및 치료용 약학적 조성물을 제공한다.In order to accomplish the above object, the present invention provides a pharmaceutical composition for the prevention and treatment of menopausal disease comprising an enzyme food and collagen as an active ingredient.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 갱년기 질환 예방 및 개선용 건강기능식품을 제공한다.The present invention also provides a health functional food for the prevention and improvement of menopausal diseases containing an enzyme food and collagen as an effective ingredient.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 눈썹 육모용 약학적 조성물을 제공한다.The present invention also provides a pharmaceutical composition for eyebrow hair formation comprising an enzyme food and collagen as an active ingredient.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 손톱 강화용 약학적 조성물을 제공한다.The present invention also provides a pharmaceutical composition for enhancing nails comprising an enzyme food and collagen as an effective ingredient.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 눈썹 육모용 건강기능식품을 제공한다.The present invention also provides a health functional food for eyebrow hair formation comprising an enzyme food and collagen as an active ingredient.
아울러, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 손톱 강화용 건강기능식품을 제공한다.
In addition, the present invention provides a health functional food for nail strengthening comprising an enzyme food and collagen as an active ingredient.
본 발명의 효소 식품(enzyme food) 및 콜라겐(collagen)을 유효성분으로 함유하는 조성물은 갱년기 증상으로 인해 떨어지는 소화 흡수력을 개선시키고, 체내 단백질 농도를 증가시켜 유의적인 눈썹 육모 효과 및 손톱 강화 효과를 나타내며, 특히 효소 식품 단독 및 콜라겐 단독 처리군과 비교하여 현저한 상승효과(synergy effect)를 나타내므로, 갱년기 여성을 위한 눈썹 육모용 조성물 또는 손톱 강화용 조성물의 유효성분으로 유용하게 사용될 수 있다.
The composition containing the enzyme food and collagen as an active ingredient of the present invention improves the digestive absorption ability due to menopausal symptoms and increases the concentration of protein in the body, thereby exhibiting significant eyebrow hair growth effect and nail strengthening effect , Especially the enzyme food alone and the group treated with collagen alone, exhibit a remarkable synergy effect, and thus can be effectively used as an effective ingredient of a composition for eyebrow hair growth or a nail strengthening composition for menopausal women.
도 1은 눈썹 길이의 측정방법을 나타낸 도이다.
도 2는 눈썹 두께의 측정방법을 나타낸 도이다.
도 3은 눈썹의 단위면적당 개수를 측정하는 방법을 나타낸 도이다.
도 4는 눈썹 짙기 변화를 확인하는 방법을 나타낸 도이다.
도 5는 눈썹의 짙기 정도 변화를 확인한 도이다:
C: 콜라겐 단독 처리군; 및
EC: 본 발명의 효소 식품 및 콜라겐 처리군.
도 6은 60대 여성을 대상으로 눈썹의 짙기 정도 변화를 확인한 도이다:
EC: 본 발명의 효소 식품 및 콜라겐 처리군.
도 7은 식이 이전 및 이후의 손톱의 두께 변화를 나타낸 도이다.
도 8은 식이 이전 및 이후의 손톱의 밀도 변화를 나타낸 도이다.1 is a view showing a method of measuring eyebrow length.
2 is a view showing a method of measuring eyebrow thickness.
3 is a diagram illustrating a method for measuring the number of eyebrows per unit area.
Fig. 4 is a diagram showing a method for confirming the change in brow thickness. Fig.
Fig. 5 is a view showing changes in the degree of darkness of eyebrows:
C: collagen alone group; And
EC: Enzyme food and collagen treatment group of the present invention.
FIG. 6 is a chart showing changes in the degree of eyebrows in 60s women:
EC: Enzyme food and collagen treatment group of the present invention.
Fig. 7 is a graph showing changes in the thickness of the nails before and after the diet. Fig.
Fig. 8 is a diagram showing the density change of the nails before and after the formula. Fig.
이하, 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명은 효소 식품(enzyme food) 및 콜라겐(collagen)을 유효성분으로 함유하는 갱년기 질환 예방 및 치료용 약학적 조성물을 제공한다.The present invention provides a pharmaceutical composition for the prevention and treatment of menopausal disease comprising an enzyme food and collagen as an active ingredient.
상기 효소 식품은 식용 미생물을 배양한 것 또는 배아, 과일, 채소, 곡류 등에서 효소함유 부분을 추출한 것 또는 이를 주원료로 하여 먹기 좋도록 여러 형태로 가공한 곡류 효소 식품을 의미하는 것으로, 제조된 것, 시판되는 효소 식품 어느 것을 이용하여도 무방하다.The enzyme food refers to a cereal enzyme food obtained by culturing an edible microorganism or by extracting an enzyme-containing portion from an embryo, fruit, vegetable, or cereal, or a cereal enzyme food processed into various forms so as to be eaten as a main ingredient. Any commercially available enzyme food may be used.
또한, 효소 식품은 하기와 같이 제조되는 것이 바람직하나 이에 한정되지 않는다:In addition, the enzyme food is preferably, but not limited to, prepared as follows:
1) 곡류를 침지하는 단계;1) immersing the grain;
2) 상기 단계 1)의 침지된 곡류를 증자하는 단계;2) growing the immersed grains of step 1);
3) 상기 증자된 곡류에 Aspergillus 속 균주 또는 Bacillus 속 균주를 접종한 후, 배양하는 단계.3) Inoculating the Aspergillus sp. Strain or Bacillus sp.
상기 단계 1)의 곡류는 쌀, 보리, 밀기울 및 콩인 것이 바람직하고, 상기 침지는 곡류를 8 내지 12시간 침지시키는 것이 바람직하나 이에 한정되지 않는다.It is preferable that the cereal in step 1) is rice, barley, wheat bran and bean, and the immersion is preferably performed by immersing the cereal for 8 to 12 hours, but is not limited thereto.
상기 단계 2)의 증자는 100 내지 130℃의 증기를 이용하여 3 내지 4시간 증자하는 것이 바람직하고, 압력솥을 이용할 경우 20 내지 30분 증자하는 것이 바람직하나 이에 한정되지 않는다.The addition of the step 2) is preferably carried out for 3 to 4 hours by using steam at 100 to 130 ° C., and it is preferable that the pressure is increased for 20 to 30 minutes by using a pressure cooker, but not limited thereto.
상기 단계 3)의 균주는 nutrient broth 배지에서 30℃ 내지 40℃로 1 내지 3일간 전배양한 균주인 것이 바람직하고, 상기 균주는 Bacillus subtilis K-54 또는 Bacillus natto, Aspergillus oryzae(KCCM 11372) 또는 시판되는 황국균 종균인 것이 바람직하나 이에 한정되지 않는다.Preferably, the strain of step 3) is pre-cultured in nutrient broth medium at 30 ° C to 40 ° C for 1 to 3 days, and the strain is Bacillus subtilis K-54 or Bacillus natto , Aspergillus oryzae (KCCM 11372) or commercially available Gram-positive bacterium is preferable, but is not limited thereto.
상기 단계 3)의 접종은 증자된 곡물에 상기 전배양한 균주를 0.1%~0.3%(w/w) 접종한 후 배양하는 것이 바람직하다.Preferably, the inoculation of step 3) is performed after inoculating 0.1% to 0.3% (w / w) of the pre-cultured strain to the grown cereals.
본 발명의 효소 식품은 쌀을 원료로 Aspergillus oryzae를 배양시켜 쌀 효소 식품을 제조하고, 콩을 원료로 Bacillus subtilis 또는 Bacillus natto를 배양시켜 콩 효소 식품을 제조한 다음, 상기 쌀 효소 식품 및 콩 효소 식품을 1: 0.5 내지 2 중량비, 바람직하게는 1:1 중량비로 혼합하여 사용하는 것이 바람직하다.The enzyme food of the present invention contains Aspergillus oryzae are cultured to produce rice enzyme food, and soybean enzyme food is prepared by culturing Bacillus subtilis or Bacillus natto with soybean as a raw material. Then, the rice enzyme food and the soybean enzyme food are mixed at a ratio of 1: 0.5 to 2, It is preferable to mix them in a weight ratio of 1: 1.
상기 콜라겐은 어류 유래 콜라겐, 동물성 콜라겐, 식물성 콜라겐을 사용할 수 있으며, 구체적으로 어류 유래 콜라겐을 사용할 수 있다.The collagen may be fish-derived collagen, animal collagen or vegetable collagen, and fish-derived collagen may be specifically used.
상기 효소 식품 및 콜라겐은 1: 0.5 내지 2 중량비로 혼합하는 것이 바람직하고, 1:1 중량비로 혼합하는 것이 보다 바람직하다.The enzyme food and the collagen are preferably mixed at a weight ratio of 1: 0.5 to 2, more preferably at a weight ratio of 1: 1.
상기 갱년기 질환은 50대 전후하여 여성호르몬인 에스트로겐의 분비가 저하되면서 발병하는 질환을 의미하는 것으로, 에스트로겐은 여성 성기능을 유지할 뿐만 아니라 혈액순환, 체중조절, 뼈 관리를 돕는 등의 다양한 기능을 한다. 따라서, 갱년기가 되어 에스트로겐 분비가 감소하면 이로 인한 여러 가지 신체 변화를 수반된다. 상기 갱년기 질환의 주된 원인은 에스트로겐 분비 저하로 난소 절제, 난소 기능저하 등 다른 원인에 의한 에스트로겐 결핍에서 오는 질환도 본 발명의 갱년기 질환에 포함된다. 상기 갱년기 질환의 비제한적인 예로는 갱년기성 골다공증, 안면홍조, 복부비만, 자궁위축, 인지장애, 알츠하이머, 혈류장애, 다한증 및 피부 노화 등이 있으며, 본 발명의 갱년기 질환은 눈썹 탈모 또는 조갑(nail) 질환인 것이 바람직하다.
The above-mentioned menopausal disease refers to a disease that occurs when the secretion of estrogen, the female hormone, is lowered around about 50 years, and estrogen functions not only to maintain female sexual function, but also to help blood circulation, weight control and bone management. Therefore, when estrogen secretion decreases as it becomes a menopause, it causes various body changes. The main causes of the menopausal disease include osteoporosis due to lowering of estrogen secretion, diseases caused by estrogen deficiency due to other causes such as ovarian function deterioration, and the like. Non-limiting examples of the menopausal diseases include menopausal osteoporosis, facial flushing, abdominal obesity, cervical atrophy, cognitive disorders, Alzheimer's disease, blood flow disorders, hyperhidrosis and skin aging. The menopausal diseases of the present invention include eyebrow hair loss or nail ) Diseases.
본 발명의 구체적인 실시예에서, 본 발명자들은 40~60대 연령의 중년 여성을 대조군(Cont.), 효소 식품 식이의 효소군(E), 콜라겐 섭취의 콜라겐군(C), 효소 식품과 콜라겐 복합섭취군(EC)으로 분류한 후, 각각의 그룹에 무처리, 효소 식품 단독, 콜라겐 단독 또는, 효소 식품 및 콜라겐을 식이한 후, 눈썹의 길이, 두께, 개수, 손상도, 짙기를 측정하였다.In a specific example of the present invention, the inventors of the present invention found that middle-aged women aged 40 to 60 were treated with a control (Cont.), An enzyme group (E) of enzyme food diet, a collagen group of collagen ingestion (C) The length, thickness, number, degree of damage, and thickening of eyebrows were measured after dietary treatment, enzyme food alone, collagen alone, enzyme food, and collagen were fed to each group.
구체적으로, 효소 식품과 콜라겐의 복합 섭취가 40~60대 중년 여성의 눈썹에 미치는 영향을 확인하기 위하여, 실험 전후 눈썹 길이를 스튜디오에서 촬영한 눈썹 길이 측정용 사진을 포토샵의 ruler 기능을 이용하여 측정한 결과(도 1 참조), 본 발명의 효소 식품과 콜라겐의 복합 섭취가 대조군, 효소 식품 단독 처리군, 콜라겐 단독 처리군과 비교하여 눈썹 길이를 유의적으로 증가시키는 것을 확인하였다(표 2 참조).Specifically, in order to examine the effect of the combined use of enzyme food and collagen on the eyebrows of middle-aged women in their 40s and 60s, eyebrow length measurements taken in the studio before and after the experiment were measured using the ruler function of Photoshop (See FIG. 1), it was confirmed that the combined ingestion of the enzyme food and collagen of the present invention significantly increased the eyebrow length as compared with the control group, enzyme food alone treatment group, and collagen alone treatment group (see Table 2) .
또한, 본 발명자들은 효소 식품과 콜라겐의 복합 섭취 전후 눈썹 두께 변화를 확인하기 위하여, 효소 식품과 콜라겐의 복합 섭취 전후 모발진단기로 촬영한 3.6 mm × 2.8 mm 사진에 모발 진단기를 사용하여 눈썹의 직경을 측정하는 방법으로, 두께를 5회 반복 측정하여 그 평균값을 수치화한 결과(도 2 참조), 발명의 효소 식품과 콜라겐의 복합 섭취군은 대조군, 효소 식품 단독 처리군, 콜라겐 단독 처리군과 비교하여 눈썹 두께를 유의적으로 증가시키는 것을 확인하였다(표 3 참조).In order to examine changes in the thickness of the eyebrows before and after the combined use of enzyme food and collagen, the present inventors measured the diameter of the eyebrows using a hair stylist on a 3.6 mm x 2.8 mm photograph taken with a hair stylist before and after the combination of enzyme food and collagen As a measurement method, the thickness was repeatedly measured five times and the average value thereof was numerically expressed (see Fig. 2). The inventive enzyme food and collagen combination group were compared with the control group, the enzyme food alone group, and the collagen alone group It was confirmed that eyebrow thickness was significantly increased (see Table 3).
또한, 본 발명자들은 효소 식품과 콜라겐 복합 섭취가 눈썹의 개수에 미치는 효과를 확인하기 위하여, 모발진단기로 촬영한 3.6 mm × 2.8 mm 사진으로 모근을 기준으로 하여 모발의 개수를 측정한 결과, 발명의 효소 식품과 콜라겐의 복합 섭취군은 대조군, 효소 식품 단독 처리군, 콜라겐 단독 처리군과 비교하여 눈썹의 개수를 유의적으로 증가시키는 것을 확인하였다(표 4 참조).In addition, in order to confirm the effect of the enzyme food and collagen combination on the number of eyebrows, the present inventors measured the number of hairs based on hair roots with a 3.6 mm x 2.8 mm photograph taken with a hair styling machine. As a result, The number of eyebrows was significantly increased in the combined group of enzyme food and collagen compared to control group, enzyme food alone group, and collagen alone group (see Table 4).
또한, 본 발명의 효소 식품 및 콜라겐 복합 섭취의 눈썹 밀도에 대한 효과를 확인하기 위하여, 효소 식품과 콜라겐 복합 섭취 전후의 눈썹의 밀도를 간접적으로 볼 수 있는 흡광도 분석을 수행한 결과, 본 발명의 조성물은 효소 식품 및 콜라겐의 상승작용을 통해, 효소 식품 또는 콜라겐 단독처리군, 및 대조군과 비교하여 눈썹 밀도를 유의적으로 증가시키는 것을 확인하였다(표 5 참조).In order to confirm the effect of the enzyme food and collagen complex intake of the present invention on the eyebrow density, the absorbance analysis was performed to indirectly observe the density of eyebrows before and after the enzyme food and collagen composite intake. As a result, Showed significant increase in eyebrow density as compared with enzyme food or collagen alone treatment group and control group through synergistic action of enzyme food and collagen (see Table 5).
또한, 본 발명자들은 효소 식품과 콜라겐 복합 섭취 전후의 눈썹 짙기 변화를 확인한 결과(도 4), 본 발명의 조성물은 효소 식품 또는 콜라겐 단독처리군, 및 대조군과 비교하여 눈썹 짙기에 유의적인 효과를 나타냄을 확인하였다(표 6 참조).Further, the inventors of the present invention found that the composition of the present invention had a significant effect on eyebrow darkness compared to the enzyme food or collagen alone treatment group and the control group, as a result of examining changes in eyebrow darkness before and after consumption of enzyme food and collagen combination (See Table 6).
아울러, 본 발명자들은 효소 식품과 콜라겐 복합 섭취의 손톱개선 효과를 확인하기 위하여, 손톱의 두께 변화 및 밀도 변화를 확인한 결과, 본 발명의 조성물은 효소 식품 또는 콜라겐 단독처리군, 및 대조군과 비교하여 손톱 두께(도 7 참조) 및 밀도(도 8 참조)를 현저히 증가시키는 것을 확인하였다.The inventors of the present invention found that changes in thickness and density of nails were observed in order to confirm the nail improving effect of the enzyme food and collagen composite intake. As a result, the composition of the present invention was compared with the enzyme food or collagen alone group, (See FIG. 7) and the density (see FIG. 8) of the present invention.
따라서, 본 발명의 조성물은 갱년기로 인해 떨어지는 소화 흡수력을 개선시키고, 체내 단백질 농도를 증가시켜 유의적인 눈썹 육모 효과 및 손톱 강화 효과를 나타내며, 특히 효소 식품 단독 및 콜라겐 단독 처리군과 비교하여 현저한 상승효과(synergy effect)를 나타내므로, 갱년기 여성을 위한 눈썹 육모용 조성물 또는 손톱 강화용 약학적 조성물의 유효성분으로 유용하게 사용될 수 있다.
Therefore, the composition of the present invention shows significant increase in eyebrow hair growth effect and nail strengthening effect by improving the digestive absorption power which is lowered due to menopausal period, increasing protein concentration in the body, and especially remarkable synergistic effect compared with enzyme food alone and collagen alone treatment group (synergy effect), it can be usefully used as an active ingredient of a composition for eyebrow hair growth or a composition for nail strengthening for menopausal women.
본 발명의 조성물은 경구 또는 비경구 투여(예를 들어, 도포 또는 정맥 내, 피하, 복강 내 주사)할 수 있으나 경구 투여가 바람직하다. 비경구 투여를 위한 제제로는 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 멸균된 수용액, 액제, 비수성용제, 현탁제, 에멀젼, 시럽, 좌제, 에어로졸 등의 외용제 및 멸균 주사제제의 형태로 제형화하여 사용될 수 있으며, 바람직하게는 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플 라스마제의 피부 외용 약학적 조성물을 제조하여 사용할 수 있으나, 이에 한정하는 것은 아니다. 국소 투여의 조성물은 임상적 처방에 따라 무수형 또는 수성형일 수 있다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다. 경구 투여를 위한 고형제제에는 산제, 과립제, 정제, 캡슐제, 연질캅셀제, 환 등이 포함된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제, 에어로졸 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.The composition of the present invention can be administered orally or parenterally (e.g., applied or intravenously, subcutaneously, intraperitoneally), but oral administration is preferred. As the agent for parenteral administration, the external preparation such as powders, granules, tablets, capsules, sterilized aqueous solutions, liquid preparations, non-aqueous solutions, suspensions, emulsions, syrups, suppositories and aerosols, The composition may be formulated in the form of a cream, a gel, a patch, a spray, an ointment, a warning agent, a lotion, a liniment, a pasta or a cataplasm. However, the present invention is not limited thereto. The composition for topical administration may be anhydrous or water-based, depending on the clinical formulation. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of suppository bases include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin, and the like. Solid form preparations for oral administration include powders, granules, tablets, capsules, soft capsules, and the like. Examples of liquid formulations for oral use include suspensions, solutions, emulsions, syrups and aerosols. In addition to water and liquid paraffin which are commonly used simple diluents, various excipients such as wetting agents, sweeteners, fragrances and preservatives .
상기 조성물은 투여를 위해서 본 발명의 조성물의 유효성분 이외에 추가로 약제학적으로 허용 가능한 담체를 1종 이상 포함하여 제조할 수 있다. 약제학적으로 허용 가능한 담체는 식염수, 멸균수, 링거액, 완충 식염수, 덱스트로즈 용액, 말토 덱스트린 용액, 글리세롤, 에탄올 및 이들 성분 중 1 성분 이상을 혼합하여 사용할 수 있으며, 필요에 따라 항산화제, 완충액, 정균제 등 다른 통상의 첨가제를 첨가할 수 있다. 또한, 희석제, 분산제, 계면활성제, 결합제 및 윤활제를 부가적으로 첨가하여 수용액, 현탁액, 유탁액 등과 같은 주사용 제형 등으로 제제화할 수 있다.The composition may be prepared by incorporating at least one pharmaceutically acceptable carrier in addition to the active ingredient of the composition of the present invention for administration. The pharmaceutically acceptable carrier may be a mixture of saline, sterilized water, Ringer's solution, buffered saline, dextrose solution, maltodextrin solution, glycerol, ethanol and one or more of these components. If necessary, an antioxidant, , And other conventional additives such as a bacteriostatic agent may be added. In addition, a diluent, a dispersant, a surfactant, a binder and a lubricant may be additionally added to formulate the composition for injectable use such as an aqueous solution, a suspension or an emulsion.
본 발명에 따른 약제학적으로 허용가능한 첨가제는 상기 조성물에 대해 0.1~90 중량부 포함되는 것이 바람직하다.The pharmaceutically acceptable additives according to the present invention are preferably contained in an amount of 0.1 to 90 parts by weight based on the composition.
본 발명의 조성물의 바람직한 투여량은 체내에서 활성성분의 흡수도, 환자의 연령, 성별 및 비만의 정도에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 경구 투여제의 경우 일반적으로 성인에게 1일에 체중 1㎏당 본 발명의 조성물을 1일 0.4 내지 0.8 g/㎏으로, 바람직하게는 0.5 내지 0.7 g/㎏으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The preferred dosage of the composition of the present invention varies depending on the degree of absorption of the active ingredient in the body, the age of the patient, the sex, and the degree of obesity, but can be appropriately selected by those skilled in the art. For the desired effect, however, in the case of oral administration, administration of the composition of the present invention is generally 0.4 to 0.8 g / kg per day, preferably 0.5 to 0.7 g / kg per 1 kg of body weight per day to an adult good. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.
본 발명의 조성물은 본 발명의 효소 식품 및 콜라겐에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다.
The composition of the present invention may contain at least one active ingredient which exhibits the same or similar functions in addition to the enzyme food and collagen of the present invention.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 갱년기 질환 예방 및 개선용 건강기능식품을 제공한다.The present invention also provides a health functional food for the prevention and improvement of menopausal diseases containing an enzyme food and collagen as an effective ingredient.
본 발명의 조성물은 갱년기로 인해 떨어지는 소화 흡수력을 개선시키고, 체내 단백질 농도를 증가시켜 유의적인 눈썹 육모 효과 및 손톱 강화 효과를 나타내며, 특히 효소 식품 단독 또는 콜라겐 단독 처리군과 비교하여 현저한 상승효과(synergy effect)를 나타내므로, 갱년기 여성을 위한 눈썹 육모용 건강기능식품 또는 손톱 강화용 건강기능식품의 유효성분으로 유용하게 사용될 수 있다.
The composition of the present invention improves digestion and absorption power due to menopausal symptoms, increases protein concentration in the body, exhibits significant eyebrow hair growth effect and nail strengthening effect, and particularly shows synergy effect, it can be usefully used as an active ingredient of health functional foods for eyebrow hair growth or health functional foods for nail strengthening for menopausal women.
본 발명의 효소 식품 및 콜라겐 혼합물을 식품 또는 음료 첨가물로 사용할 경우, 상기 효소 식품 및 콜라겐 혼합물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용되고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 상기 효소 식품 및 콜라겐 혼합물의 혼합양은 그의 사용목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 건강 및 위생을 목적으로 하거나 또는 건강조절을 목적으로 하는 장기간의 섭취의 경우, 상기 효소 식품 및 콜라겐 혼합물은 안전성 면에서 아무런 문제가 없기 때문에, 장기간 복용이 가능하다. 상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 초콜릿류, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등이 있다. 음료수로 제형화할 경우에 효소 식품 및 콜라겐 혼합물 이외에 첨가되는 액체 성분으로는 이제 한정되지는 않으나, 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드(예, 포도당, 과당 등), 디사카라이드(예, 말토오스, 수크로오스 등) 및 폴리사카라이드(예, 덱스트린, 시클로덱스트린 등과 같은 통상적인 당), 및 자일리톨, 소르비톨, 에리스리톨 등의 당 알코올이다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖ 당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다. 상술한 것 이외의 향미제로서 천연 향미제[타우마린, 스테비아 추출물(예, 레바우디오시드 A, 글리시르히진 등)] 및 합성 향미제(예, 사카린, 아스파르탐 등)를 사용할 수 있다.When the enzyme food and collagen mixture of the present invention is used as a food or beverage additive, the enzyme food and the collagen mixture may be added directly or used together with other food or food ingredients, and suitably used according to a conventional method. The amount of the enzyme food and the amount of the collagen mixture to be mixed can be suitably determined according to the purpose of use (prevention, health or therapeutic treatment). In the case of long-term intake for health and hygiene purposes or for health control purposes, the enzyme food and collagen mixture can be taken for a long period of time because of no safety problems. There is no particular limitation on the kind of the food. Examples of foods to which the above substances can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, , Alcoholic beverages and vitamin complexes. When formulated into a beverage, the liquid ingredient to be added in addition to the enzyme food and the collagen mixture is not limited to the present, but may include various flavors or natural carbohydrates such as ordinary beverages as an additional ingredient. Examples of such natural carbohydrates include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose and polysaccharides such as those commonly used in dextrin and cyclodextrins, , Sorbitol, and erythritol. The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the composition of the present invention. Natural flavors such as taumarin and stevia extract (e.g., rebaudioside A and glycyrrhizin) and synthetic flavorings (e.g., saccharin, aspartame, etc.) can be used as flavors other than those described above .
다른 양태로서, 본 발명의 식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 또한, 본 발명의 식품 조성물은 과일 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 단독으로 또는 조합으로 사용될 수 있으며, 이러한 첨가제의 비율은 조성물 전체 중량당 0.001 내지 50 중량부의 범위에서 선택되는 것이 일반적이다.
In another aspect, the food composition of the present invention may be formulated into various flavors such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, , Protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. In addition, the food composition of the present invention may contain pulp for the production of fruit and vegetable drinks. These components may be used singly or in combination, and the proportion of such additives is generally selected in the range of 0.001 to 50 parts by weight based on the total weight of the composition.
또한, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 눈썹 육모용 약학적 조성물, 및 건강기능식품을 제공한다.The present invention also provides a pharmaceutical composition for eyebrow hair formation comprising an enzyme food and collagen as an active ingredient, and a health functional food.
본 발명의 구체적인 실시예에서, 본 발명자들은 본 발명의 효소 식품 및 콜라겐이 눈썹의 길이, 두께, 개수, 밀도 및 눈썹 짙기를 유의적으로 증가시키는 것을 확인하였다(표 2 내지 표 6 참조)In a specific embodiment of the present invention, the present inventors have confirmed that the enzyme food and collagen of the present invention significantly increase the length, thickness, number, density and eyebrow darkness of the eyebrows (see Tables 2 to 6)
따라서, 본 발명의 효소 식품 및 콜라겐은 눈썹 육모용 약학적 조성물 및 건강기능식품의 유효성분으로 유용하게 사용될 수 있다.
Therefore, the enzyme food and collagen of the present invention can be effectively used as an effective ingredient of a pharmaceutical composition for eyebrow hair growth and a health functional food.
아울러, 본 발명은 효소 식품 및 콜라겐을 유효성분으로 함유하는 손톱 강화용 약학적 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for enhancing nails comprising an enzyme food and collagen as an active ingredient.
본 발명의 구체적인 실시예에서, 본 발명자들은 본 발명의 효소 식품 및 콜라겐이 손톱의 두께 및 밀도를 현저히 증가시키는 것을 확인하였다(도 7 및 도 8 참조)In a specific embodiment of the present invention, the inventors have confirmed that the enzyme food and collagen of the present invention significantly increase the thickness and density of nails (see FIGS. 7 and 8)
따라서, 본 발명의 효소 식품 및 콜라겐은 손톱 강화용 약학적 조성물 및 건강기능식품의 유효성분으로 유용하게 사용될 수 있다.
Therefore, the enzyme food and collagen of the present invention can be effectively used as an effective ingredient of a pharmaceutical composition for nail strengthening and a health functional food.
이하 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples.
단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 한정되는 것은 아니다.
However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the present invention is not limited to the following Examples and Experimental Examples.
<< 실시예Example 1> 실험 대상의 선정 1> Selection of experiment subjects
본 발명은 서울, 경기에 거주하는 40~60대 연령의 중년 여성을 대상으로 하였다. 실험 대상자는 난소절제술 혹은 자궁 적출술을 받지 않았고, 최근 1년 이내에 여성 호르몬 치료를 받지 않았으며, 최근 6개월간 특정 약물이나 특별 식이요법을 하지 않은 여성으로, 현재 내과적으로 치료를 받고 있지 않는 대상자를 선정하였다. 또한, 선정된 실험대상자는 실험기간 동안 건강보조식품과 혈관 확장 및 탈모 관련 약물을 복용하지 않을 것을 동의하였다. 실험 대상자들에게 본 실험의 취지와 목적에 대해 설명한 후, 임상 참여 동의서를 받았으며, 실험기간은 2013년 4월부터 2013년 6월까지 12주에 걸쳐 진행되었다. 실험 대상자는 총 48명이며, 대조군(Cont.) 12명, 효소 식품 식이의 효소 식품군(E) 12명, 콜라겐 섭취의 콜라겐군(C) 12명, 효소 식품과 콜라겐 복합섭취군(EC) 12명씩 네 개의 그룹으로 나누어 실험을 진행하였다.
The present invention is directed to middle-aged women aged 40 to 60 living in Seoul and Gyeonggi-do. The subjects were women who had not undergone ovarian resection or hysterectomy, who had not received hormone therapy within the past year, and who had not received any medication or special dietary therapy for the past 6 months. Respectively. Also, the selected subjects agreed that they would not take the health supplement and vasodilating and hair loss related drugs during the experiment. After explaining the purpose and purpose of the experiment to the subjects, they received the agreement of clinical participation. The experiment period was from April, 2013 to June, 2013 for 12 weeks. A total of 48 subjects were included in the study. Twelve control subjects (12), enzyme food group (E) 12, collagen group (C) 12, enzyme food and collagen combination group 12 The experiment was divided into four groups.
<< 실시예Example 2> 실험 재료의 준비 2> Preparation of experimental material
<2-1> 쌀 효소 식품의 제조<2-1> Production of rice enzyme food
효소 식품은 식물성 원료에 식용미생물을 배양시켜 효소를 다량 함유하게 하거나 식품에서 효소함유부분을 추출한 것 또는 이를 주원료로 하여 섭취가 용이하도록 가공한 것을 의미(대한민국, 식품공전)하는 것으로, 본 발명자들은 쌀을 원료로 Aspergillus oryzae를 배양시켜 쌀 효소 식품을 제조하였다.The enzyme food means that the edible microorganism is cultivated in the vegetable raw material to contain a large amount of the enzyme or the enzyme-containing portion is extracted from the food, or the processed food is processed to facilitate the ingestion with the main ingredient as the main ingredient (Korea Food Research Institute) Aspergillus rice as raw material oryzae were cultured to produce rice enzyme food.
구체적으로, 쌀을 세척하여 4~5 시간 물에 침지시킨후, 물을 빼고 상압에서 2시간 증자한 다음 40℃로 냉각한 후, malt extract broth 배지에서 35℃로 2일간 전배양한 Aspergillus oryzae(KCCM 11372)를 쌀 무게의 0.1%~0.3%(w/w) 접종하였다. 균접종한 쌀을 30℃ 배양기에서 72시간 배양한 후 건조한 다음, 분쇄하여 쌀 효소 식품을 제조하였다.
Specifically, the rice was washed and immersed in water for 4 to 5 hours. Then, water was removed, and the mixture was incubated at normal pressure for 2 hours. The rice was cooled to 40 ° C and then cultured in malt extract broth medium at 35 ° C for 2 days. Aspergillus oryzae (KCCM 11372) were inoculated 0.1% to 0.3% (w / w) of rice weight. The inoculated rice was cultured for 72 hours at 30 ℃ in an incubator, dried and then pulverized to prepare rice enzyme food.
<2-2> 콩 효소 식품의 제조 <2-2> Production of soybean enzyme food
본 발명자들은 콩을 원료로 Bacillus subtilis 또는 Bacillus natto를 배양시켜 콩 효소 식품을 제조하였다.The present inventors produced soybean enzyme food by culturing Bacillus subtilis or Bacillus natto with soybean as a raw material.
구체적으로, 콩 효소 식품을 제조하기 위하여, 상온에서 콩을 10시간 동안 물에 침지시킨 다음, 압력솥을 이용하여 120℃에서 25분간 증자하였다. 그런 다음, Bacillus subtilis K-54 또는 Bacillus natto를 nutrient broth 배지에서 35℃로 2일간 전배양한 후, 상기 전배양한 균주를 콩에 0.1%~0.3%(w/w) 접종한 후 청국장배양기(37~39℃)에서 1일간 배양하였다. 이후 동결건조하고 분쇄하여, 콩 효소 식품을 제조하였다.
Specifically, in order to produce soybean enzyme food, beans were immersed in water for 10 hours at room temperature, and then were heated at 120 DEG C for 25 minutes using a pressure cooker. Then, Bacillus subtilis K-54 or Bacillus natto was preincubated in nutrient broth medium at 35 ° C for 2 days, and the pre-cultured strain was inoculated with 0.1% to 0.3% (w / w) 37 ~ 39 ° C) for 1 day. Thereafter, the soybean enzyme food was prepared by lyophilization and pulverization.
<2-3> 본 발명의 효소 식품의 제조≪ 2-3 > Production of Enzyme Food of the Present Invention
본 발명의 효소 식품은 상기 <2-1>에서 제조한 쌀 효소 식품과 <2-2>에서 제조한 콩 효소 식품을 1:1의 중량비로 혼합하여 하기 실험에 이용하였다.
The enzyme food of the present invention was used in the following experiment by mixing the rice enzyme food prepared in <2-1> and the soybean enzyme food prepared in <2-2> at a weight ratio of 1: 1.
<2-4> 콜라겐의 준비 <2-4> Preparation of Collagen
본 발명의 콜라겐은 경구용 어류 콜라겐 펩타이드(marine collagen peptide)인 Collagen peptide-SP를 별도의 제조과정 없이 섭취에 용이하도록 3 g씩 진공 포장된 것을 공급받아 임상 실험 재료로 사용하였다.
Collagen peptide-SP, a marine collagen peptide of the present invention, was supplied as a 3-g vacuum packaged material to facilitate the ingestion without any manufacturing process.
<< 실시예Example 3> 3> 식이제제의Dietary 구성 Configuration
상기 <실시예 1>에서 선정한 실험 대상자들은 의도적으로 일상 식사량과 습관을 바꾸지 않고 유지하는 상태에서 총 12주 동안 매일 아침과 저녁 각각 식사 시 E는 상기 실시예 <2-3>에서 제조한 효소 식품 3 g씩, C는 상기 실시예 <2-4>에서 준비한 콜라겐 3 g씩, EC는 상기 실시예 <2-3> 및 <2-4>에서 준비한 효소 식품 3 g과 콜라겐 3 g을 함께 입안에 털어서 먹거나, 식사나 물과 함께 섭취하도록 실험 전에 유의사항과 함께 공지하였으며, Cont.은 한천가루를 동일한 방법으로 섭취하도록 설정하였다.The subjects to be selected in Example 1 were intentionally kept in the daily food quantity and habit without changing intention, and during the total of 12 weeks in the morning and evening, E was added to the enzyme food prepared in Example <2-3> 3 g of the collagen prepared in Example <2-4>, 3 g of the enzyme preparation prepared in Examples <2-3> and <2-4>, and 3 g of collagen prepared in the above Example <2-4> , Or to be eaten with meals or water, together with the notes before the experiment, and Cont. Was set to consume the agar powder in the same manner.
본 발명의 효소 식품의 일일 섭취량인 6 g을 기준으로 하였으며 콜라겐 섭취량은 갱년기 여성의 콜라겐 식이에 관한 연구(이하나, 2011; 한채정, 강상모, 2008)를 근거하여 일일 6 g으로 설정하여 본 발명에서는 매일 2회, 아침과 저녁 식사 시에 각각 3 g씩 나누어 섭취하도록 하였다.
The daily intake of 6 g of the enzyme food of the present invention was used as a reference. Collagen intake was set at 6 g per day on the basis of a study on collagen diet in women of menopausal age (hereinafter referred to as 2011, Han Cheol-jung, 2 times a day, 3 g each at breakfast and dinner.
<< 실시예Example 4> 눈썹 측정 4> eyebrow measurement
본 발명에서 눈썹 측정은 식이제제의 섭취 전과 12주간의 섭취 후에 각각 수행하였다. 구체적으로 측정실 온도 24~25℃, 상대습도 40~60%의 동일한 환경에서 세안 후 30분 지난 후에 눈썹에 동일한 기기, 조명에서 측정하였으며 오차를 줄이기 위해 동일인이 처음부터 끝까지 측정하였다. 눈썹의 길이는 사진 촬영 후 프로그램을 이용하여 측정하였고, 두께와 개수는 접촉식 모발진단기를 활용하였다. 눈썹 흡광도는 methylene blue법을 이용한 실험으로 측정하였다.
In the present invention, eyebrow measurements were performed before and 12 weeks after the diet. Specifically, in the same environment of measuring room temperature of 24 ~ 25 ℃ and relative humidity of 40 ~ 60%, 30 minutes after cleansing, eyebrows were measured with the same instrument and illumination, and the same person was measured from the beginning to the end to reduce the error. Eyebrow length was measured using a program after taking a photograph, and thickness and number were measured using a contact type hair styling machine. Eyebrow absorbance was measured by the methylene blue method.
<4-1> 눈썹의 길이 측정<4-1> Measuring eyebrow length
실험 전과 3개월간의 실험 후 사진은 카메라 알파 57(SLT-A57K, Sony, Korea)를 이용하여 스튜디오에서 촬영하였고, 촬영한 사진은 포토샵(Adobe, photoshop CS2)을 이용하여 분석하였다. 눈썹의 길이는 사진 촬영 시 촬영대상자가 고정된 눈금자 위에 눈썹을 댄 후 눈동자 가운데를 기준으로 하여 눈썹을 선정한 뒤 테이프를 이용하여 눈썹 가닥을 나누고 촬영하였다. 그리고 촬영한 사진을 포토샵의 ruler 기능을 이용하여 눈금자의 길이와 비교하는 방법으로 길이를 측정하였다. 길이 측정에 사용한 눈썹개수는 5개이며, 이의 평균값을 눈썹의 길이로 사용하였다.
Before and after the experiment, the photographs were taken in the studio using Camera Alpha 57 (SLT-A57K, Sony, Korea) and the photographs were analyzed using Photoshop CS2. The length of the eyebrows was measured by taking the eyebrows on a fixed ruler when the subject was photographed, selecting eyebrows based on the center of the eyes, and then dividing the eyebrows using tape. I measured the length of the photographed image by comparing it with the ruler length using Photoshop's ruler function. The number of eyelashes used for measuring the length was 5, and the average value was used as the length of the eyebrows.
<4-2> 눈썹의 두께 및 개수 측정<4-2> Eyebrow thickness and number measurement
눈썹의 두께와 개수는 실험 대상자의 눈동자 중앙부위 수직과 눈썹 두께 가운데 기준 수평선이 만나는 곳에 펜을 이용하여 표시한 뒤, 해당 부위를 접촉식 모발진단기(Multi-cam 1000, 반도 메디칼, Korea)를 이용하여 100 배율 렌즈로 3.6 mm × 2.8 mm 면적으로 촬영한 뒤 기기를 이용하여 측정하였다.
The thickness and the number of eyebrows were measured using a pen at the center of the pupil center of the subject and the middle of the thickness of the eyebrows at the meeting of the reference horizon, and then the affected area was measured using a contact type hair diagnosis machine (Multi-cam 1000, Bando Medical, Korea) And photographed with an area of 3.6 mm × 2.8 mm with a 100 × magnification lens, and then measured using the instrument.
<4-3> 눈썹의 손상도 측정<4-3> Measurement of Eyebrow Damage
스튜디오 촬영 및 접촉식 모발진단기 사용이 끝난 후에 펜을 이용하여 표시한 부위의 눈썹을 면도칼을 이용하여 모간부 만을 3가닥씩 채취한 후 눈썹 밀도를 측정하였다. 눈썹을 모낭 부분에 가까운 쪽으로부터 5 mm로 자른 후 2% methylene blue 시약에 1시간 동안 침지시켜 착색시킨 후, 눈썹에 묻은 용액을 완전히 닦아낸 뒤 증류수와 에탄올, glacial acetic acid를 50:49:1로 만들어진 NR desorb solution 1 mL에 넣고 10분간 용출시켰다. 용출 후 눈썹을 제거한 용출액을 spectrophotometer로 660 nm에서 흡광도를 측정하였다.
After using the studio and the contact type hair styling device, eyebrows of the area indicated by using the pen were sampled with three rabbits using a razor, and eyebrow density was measured. The eyebrows were cut into 5 mm from the hair follicle and then stained with 2% methylene blue reagent for 1 hour. The eyebrows were washed with distilled water, ethanol and glacial acetic acid 50: 49: 1 And then eluted for 10 minutes in 1 mL of NR desorb solution. Absorbance was measured at 660 nm using a spectrophotometer.
<4-4> 눈썹의 짙기 정도 분석<4-4> Analysis of the depth of eyebrows
스튜디오에서 촬영한 사진을 포토샵(Adobe, photoshop CS2)을 이용하여 분석하였다. 사진을 photoshop으로 불러온 뒤 각 식험군(E, C, EC)의 실험 전후 변화가 뚜렷한 부분을 rectangular marquee tool로 실제 길이로 가로 5 mm 세로 5 mm가 되도록 선택한 뒤 해당부분을 복사하고 새로 캔버스를 만들어(preset: clipboard) 붙여 넣고 zoom tool(돋보기)를 이용하여 300%로 확대하였다. 대조군(Cont.)도 실험군과 같은 부위를 선택하였다. 전체 픽셀 수를 histogram 창(Window-Histogram)에서 확인한 뒤 magic wand tool(Tolerance 32)로 눈썹 모발을 클릭하여 선택한 범위가 눈썹 모양과 일치하면서 histogram 창의 pixels 값이 최고값이 나올 때의 pixel 수를 구한 뒤 앞에서 확인한 전체 픽셀 수로 나눠 해당 부분에서 눈썹이 차지하는 면적비를 구하여 짙은 정도를 비교하였다.
Photos taken in the studio were analyzed using Photoshop (Adobe, photoshop CS2). After the photos were imported into photoshop, select the part of each experiment group (E, C, EC) that had a clear change before and after the experiment with 5 mm width and 5 mm length as the actual length with the rectangular marquee tool. Copy the part and copy the new canvas I paste it into a preset (clipboard) and enlarge it to 300% by using the zoom tool (magnifying glass). The control group (Cont.) Also selected the same site as the experimental group. After checking the total number of pixels in the histogram window, click on the eyebrow hair with the magic wand tool (Tolerance 32) to find the number of pixels when the selected range matches the eyebrow shape and the pixels in the histogram window have the highest value The ratio of the area occupied by the eyebrows was calculated by dividing the total number of pixels by the number of pixels found in the back.
<4-5> 자료 분석<4-5> Analysis of data
본 발명의 눈썹 관련 수집된 자료는 SPSS Win 20.0을 이용하여 분석하였고, 실험 대상자의 동질성 검증을 위해 ANOVA(일원배치분산분석)를 시행하였으며, 실험 전후 변화를 파악하기 위해 paired t-test(대응표본 t검정)를 시행하였다.
The eyebrow-related data collected by the present invention were analyzed using SPSS Win 20.0, ANOVA (one-way ANOVA) was performed to verify the homogeneity of the subjects, and paired t-test t test).
<< 실시예Example 5> 손톱 측정 5> Measuring nails
<5-1> 손톱의 두께 측정<5-1> Measurement of nail thickness
손톱의 두께는 digital micrometer(Mitutoyo MDC-25PJ)를 이용하여 측정하였다. 두께 측정 시 오차의 최소화를 위해 실험실 온도 20~21℃, 습도 50~66%의 실내 환경이 조절된 방에서 동일인이 처음부터 끝까지 측정하였으며, 10회 반복 측정 후 측정값의 평균값을 구하여 평균에서 가장 먼 값을 나타내는 1명씩을 제하고 군당 12명씩으로 모든 값을 구하였다. 이 측정 방법을 12주 동안 식이 전과 식이 후 총 2회 측정하였다.
The thickness of the nail was measured using a digital micrometer (Mitutoyo MDC-25PJ). In order to minimize errors in thickness measurement, the same person was measured from the beginning to the end in a controlled room with a room temperature of 20 to 21 ° C and a humidity of 50 to 66%. After 10 repeated measurements, One person representing the distant value was subtracted and all values were obtained by 12 persons per group. This measurement method was measured twice before and after dieting for 12 weeks.
<5-2> 손톱의 밀도 측정<5-2> Measurement of density of nails
손톱의 밀도 측정은 methylene blue(MB) 염색법을 응용하여 측정하였다. 손톱 시료를 MB 2%에 담가 50℃에서 10 min간 유지하여 MB를 흡착시킨 후 49%의 ethanol과 1%의 glacial acetic acid 및 50%의 증류수로 만들어진 NR dissolve solution 5 mL에서 5분간 두었으며 spectrophotometer(SCINCO, NEOSYS-2000)를 이용하여 660 nm에서 추출된 용액의 O.D(optical density)값을 측정하였다. 밀도의 측정 시 오차의 최소화를 위해 일인당 손톱 시료 2개씩 측정한 후 평균에서 가장 먼 값을 나타내는 1명씩을 제하고 군당 11명씩으로 모든 값을 구하였다. 이 측정 방법을 12주 동안 식이 전과 식이 후 총 2회 측정하였다.
The density of nails was measured by methylene blue (MB) staining. The nail samples were immersed in MB 2% and maintained at 50 ° C for 10 min to adsorb MB, then placed in 5 ml of NR dissolve solution made of 49% ethanol, 1% glacial acetic acid and 50% distilled water, (OD) of the solution extracted at 660 nm was measured using a scanning electron microscope (SCINCO, NEOSYS-2000). To minimize the error in measuring the density, two nail samples per person were measured, and one person showing the farthest value from the average was subtracted and all values were obtained for each group. This measurement method was measured twice before and after dieting for 12 weeks.
<5-3> 자료 분석<5-3> Analysis of data
본 발명의 손톱관련 실시된 실증분석은 모두 유의수준 p<0.05에서 검정하였으며, 통계처리는 SPSS for Window Version 17.0을 이용하여 결과를 분석하였다.
All of the empirical analyzes of the nail of the present invention were tested at significance level p <0.05 and statistical processing was analyzed using SPSS for Window Version 17.0.
<< 실험예Experimental Example 1> 실험 대상자들의 눈썹 모발 상태 동질성 검증 1> Verification of eyebrow hair state homogeneity of subjects
모든 실험 대상자의 눈썹 길이, 눈썹 두께 및 개수, 눈썹 손상도에 대한 동질성 검증 결과는 상기 <실시예 4>에 개시된 방법을 이용하여 수행하였다.The results of the homology test for eyebrow length, eyebrow thickness and number, and eyebrow injuries of all subjects were performed using the method described in Example 4 above.
그 결과, 하기 표 1에 나타낸 바와 같이, Cont.과 E, C, EC의 눈썹 길이, 눈썹 두께 및 개수, 흡광도는 집단 간 유의한 차이를 나타내지 않았으므로, 동질성이 검증되었다(p<.05)(표 1).As a result, as shown in Table 1, since the eyebrow length, eyebrow thickness, number and absorbance of Cont., E, C and EC did not show a significant difference between groups, homogeneity was verified (p <.05) (Table 1).
<< 실험예Experimental Example 2> 눈썹 측정 결과 2> eyebrow measurement result
본 발명의 실험 대상자는 각각의 식이제제 효소 식품들의 통상적인 일일 섭취량인 6 g을 기준으로, 콜라겐 섭취의 통상적인 일일 섭취량인 6 g을 기준으로 하고, 3개월간 아침과 저녁에 각각 3 g씩 섭취하도록 하였으며, 이러한 복합 섭취가 40~60대 중년 여성의 눈썹에 미치는 영향을 알아보고자 실험 전후 눈썹의 변화를 측정하였다. 측정 항목은 눈썹 길이, 눈썹 두께, 눈썹 개수, 눈썹의 밀도를 간접적으로 알 수 있는 흡광도, 눈썹 짙기 등을 측정하여 분석하였다.
The subjects of the present invention were divided into three groups according to the usual daily intake of 6 g of daily intake of collagen, based on the usual daily intake of each dietary preparation enzyme food, and 3 g each in morning and evening for 3 months The changes in eyebrows were measured before and after the experiment to investigate the effect of this multiple ingestion on the eyebrows of middle - aged women in their 40s and 60s. The measurement items were analyzed by measuring eyebrow length, eyebrow thickness, number of eyebrows, absorbance to indirectly detect eyebrow density, eye brow thickness.
<2-1> 눈썹의 길이 변화 확인 <2-1> Confirmation of eyebrow length change
눈썹의 길이는 남성이 평균 54 mm, 여성이 평균 36 mm(Yoon IM et al., 2003)로 눈썹의 성장 속도는 1일에 남성이 0.16 mm, 여성이 0.15 mm이다(Myers & Hamilton, 1951). 반면 모발의 성장은 1일에 한국여성이 0.34 mm, 한국남성이 0.33 mm 가량 자란다(장병수, 이귀영, 2011). 눈썹은 두피 모발보다 느리고, 굵기도 가늘며, 길이가 짧고, 피부와의 각도도 예각으로 비스듬히 자란다(최원석 등, 2007). The length of eyebrows was 54 mm for males and 36 mm for females (Yoon IM et al., 2003). Eyebrow growth rate was 0.16 mm for males and 0.15 mm for females on 1 day (Myers & Hamilton, 1951) . On the other hand, the growth of hair is 0.34 mm for Korean women and 0.33 mm for Korean men on the 1st day (Jang, Byung Soo, Gyoung-young, 2011). Eyebrows are slower than scalp hairs, thin in length, shorter in length, and angular to the skin diagonally at an acute angle (Choi, 2007).
본 발명에서는 실험 대상자의 효소 식품과 콜라겐의 복합 섭취가 40~60대 중년 여성의 눈썹에 미치는 영향을 확인하기 위하여, 실험 전후 눈썹 길이를 스튜디오에서 촬영한 눈썹 길이 측정용 사진을 포토샵의 ruler 기능을 이용하여 측정하였다(도 1). In the present invention, in order to examine the effect of the compound food of the subject of the experiment on the eyebrows of the middle-aged women in the 40s and 60s, a photograph for measuring the eyebrow length measured in the studio before and after the experiment was used as a ruler function of Photoshop (Fig. 1).
그 결과, 표 2에 나타낸 바와 같이, 눈썹 길이에서 오른쪽 눈썹과 왼쪽 눈썹을 함께 보았을 때, Cont.는 사전 평균 0.407 cm에서 사후 0.473 cm로 15.97% 증가하였고(p<.05), E와 C는 각각 사전 평균 0.413 cm, 0.380 cm에서 사후 0.514 cm, 0.510 cm로 24.45%, 33.95% 증가하였으며(p<.01, p<.001), 본 발명의 EC는 사전 평균 0.345 cm에서 사후 0.479 cm로 38.84% 유의한 증가를 나타냄을 확인하였다(p<.001). 즉, Cont.에 비해 EC가 22.87% 더 길어진 것을 확인하였고, E와 C보다는 각각 14.39%, 4.89% 길어진 것을 확인하였다. As shown in Table 2, when the right eyebrow and the left eyebrow were viewed together, the Cont. Increased 15.97% (p <.05) from the pre-mean 0.407 cm to the posterior 0.473 cm (p <.05) (P <.01, p <.001), respectively. The EC of the present invention increased from an average of 0.345 cm to 0.479 cm at the posterior of 0.514 cm and 0.510 cm, (P <.001), respectively. That is, it was confirmed that EC was 22.87% longer than Cont. And it was 14.39% and 4.89% longer than E and C, respectively.
또한, 양쪽 눈썹 길이의 변화를 각각 보면, Cont.의 오른쪽 눈썹은 평균 사전 0.415 cm에서 사후 0.485 cm로 16.86% 증가하였고, 왼쪽 눈썹은 평균 사전 0.400 cm에서 사후 0.460 cm로 15.0% 눈썹 길이의 증가가 나타냈다(p<.05). E의 오른쪽 눈썹은 평균 사전 0.438 cm에서 사후 0.513 cm로 17.12% 증가를(p<.05), 왼쪽 눈썹은 사전 0.387 cm에서 사후 0.515 cm로 33.07% 증가하는 것을 확인하였다(p<.01). C의 오른쪽 눈썹은 평균 사전 0.374 cm에서 사후 0.478 cm로 27.81% 증가를(p<.001), 왼쪽 눈썹은 사전 0.386 cm에서 사후 0.542 cm로 40.16% 증가하였다(p<.01). EC의 오른쪽 눈썹은 평균 사전 0.345 cm에서 사후 0.481 cm로 39.42% 유의한 증가를(p<.001), 왼쪽 눈썹은 사전 0.345 cm에서 사후 0.478 cm로 38.26% 유의하게 증가하여(p<.000), 사후 양쪽 모두에서 눈썹 길이의 유의한 증가를 나타냈으며, 따라서 EC의 사후 눈썹 길이가 유의하게 더 길어짐을 확인하였다. 한편, Cont.에서 사후 눈썹이 평균 16% 증가한 것은, 본 실험의 기간이 4월 중순에서 6월 중순으로 환경의 기온 상승이 있었고, 이로 인해 눈썹의 혈액순환이 원활해져 모발 성장이 나타난 것으로 추정된다(표 2). In addition, when the length of both eyebrows were changed, the right eyebrow of Cont. Was increased from 16.46% to 0.485 cm from the mean of 0.415 cm, and the left eyebrow was increased from 0.400 cm to 0.460 cm posteriorly by 15.0% (P <.05). The right eyebrows of E increased 17.12% (p <.05) from the mean of 0.438 cm to 0.513 cm posteriorly and the left eyebrows increased 33.07% from 0.387 cm to 0.515 cm posteriorly (p <.01). The right eyebrows of C increased 27.81% (p <.001) from 0.474 cm to 0.478 cm, and the left eyebrows increased by 40.16% from 0.386 cm to 0.542 cm postoperatively (p <.01). The right eyebrows of the EC increased significantly (p <.001) from 39.42% (p <.001) to 0.481 cm (p <.001) , And the posterior eyebrows showed a significant increase in length, thus confirming that the posterior eyebrow length of the EC was significantly longer. On the other hand, the average increase in posterior eyebrows by 16% in Cont. Is due to the increase of temperature in the mid-April to mid-June of this experiment, which leads to smooth circulation of the eyebrows and hair growth Table 2).
<2-2> 눈썹의 두께 변화 확인<2-2> Confirmation of eyebrow thickness change
효소 식품과 콜라겐의 복합 섭취 전후 눈썹 두께 변화를 확인하기 위하여, 효소 식품과 콜라겐의 복합 섭취 전후 모발진단기로 촬영한 3.6 mm × 2.8 mm 사진에 모발 진단기를 사용하여 눈썹의 직경을 측정하는 방법으로, 두께를 5회 반복 측정하여 그 평균값을 수치화하였다(도 2).To determine the changes in the thickness of the eyebrows before and after the combined use of enzyme food and collagen, a method of measuring the eyebrow diameter using a hair stylist on a 3.6 mm × 2.8 mm photograph taken with a hair stylist before and after the combined use of enzyme food and collagen, The thickness was repeatedly measured five times, and the average value thereof was quantified (FIG. 2).
그 결과, 하기 표 3에 나타낸 바와 같이, 눈썹 두께에서 오른쪽과 왼쪽을 함께 보았을 때, Cont.는 사전 평균 0.045 mm에서 사후 0.049 mm로 6.67% 증가를(p<.05), E와 C는 각각 사전 평균 0.054 mm, 0.049 mm에서 사후 0.062 mm, 0.061 mm로 14.81% 증가 경향과 22.45% 증가를 나타냈다(p<.01). EC는 사전 평균 0.043 mm에서 사후 0.063 mm로 44.18% 유의한 증가를 나타내(p<.001), Cont.에 비해 EC가 37.51% 더 많이 두꺼워진 것을 확인할 수 있었고, E와 C보다는 각각 29.37%, 21.73% 더 두꺼워진 것을 확인하였다. As a result, as shown in Table 3 below, when the right and left sides of the eyebrow thickness were viewed together, Cont. Increased 6.67% (p <.05) from the pre-mean 0.045 mm to the posterior 0.049 mm, and E and C There was a tendency to increase 14.81% and 22.45% (p <.01) from 0.054 mm and 0.049 mm in the pre-test to 0.062 mm and 0.061 mm in the post test, respectively. EC was significantly increased from 0.043 mm to 0.063 mm postoperatively (44.18%, p <.001), and EC was 37.51% greater than Cont. 21.73% thicker.
또한, 양쪽 눈썹 두께의 변화를 각각 보면, Cont.의 오른쪽 눈썹은 사전 평균 0.044 mm에서 사후 0.046 mm로 4.54% 증가하는 경향을 보였고, 왼쪽 눈썹은 사전 0.047 mm에서 사후 0.052 mm로 10.63% 증가 경향을 나타냈다. E의 오른쪽 눈썹은 사전 평균 0.054 mm에서 사후 0.058 mm로 5.55% 증가 경향을 나타냈고, 왼쪽 눈썹은 사전 0.054 mm에서 사후 0.067 mm로 24.07% 증가를 나타내(p<.01), 양쪽 눈썹 모두에서 증가 경향을 보였다. C의 오른쪽 눈썹은 사전 평균 0.049 mm에서 사후 0.062 mm로 26.53% 증가를 보였고(p<.01), 왼쪽 눈썹은 사전 0.050 mm에서 사후 0.060 mm로 20% 유의한 증가를 나타냈다(p<.01). EC의 오른쪽 눈썹은 사전 평균 0.044 mm에서 사후 0.064 mm로 45.45% 유의한 증가를 보였고(p<.001), 왼쪽 눈썹은 사전 0.043 mm에서 사후 0.061 mm로 41.86% 유의한 증가를 나타냄을 확인하였다(p<.001). 한편, 대조군에서도 눈썹이 두꺼워지는 경향을 보인 것은 눈썹 길이에서와 같이 기온상승에서 오는 정상적인 생리적 기전으로 해석된다(표 3).In addition, the right eyebrows tended to increase by 4.54% from 0.044 mm to 0.046 mm, and the left eyebrows tended to increase by 10.63% from 0.047 mm to 0.052 mm after surgery. . The right eyebrows of E showed a tendency to increase by 5.55% from 0.054 mm to 0.058 mm, and the left eyebrows increased by 24.07% from 0.054 mm to 0.067 mm (p <.01) Respectively. The right eyebrows of C increased by 26.53% from 0.049 mm preoperatively to 0.062 mm postoperatively and the left eyebrows increased by 20% from 0.050 mm to 0.060 mm postoperatively (p <.01) . EC right eyebrows increased significantly from 0.044 mm preoperatively to 0.064 mm postoperatively (p <.001) (p <.001) and the left eyebrow significantly increased from 0.043 mm to 0.061 mm postoperatively (41.86%) p <.001). On the other hand, the tendency of eyebrows to thicken in the control group is interpreted as the normal physiological mechanism that comes from rising temperature, as in eyebrow length (Table 3).
<2-3> 눈썹의 단위면적당 개수 변화 확인<2-3> Confirmation of changes in eyebrows per unit area
효소 식품과 콜라겐 복합 섭취가 40~60대 중년 여성의 눈썹에 미치는 영향을 알아보고자 눈썹의 개수를 측정하였다. 눈썹의 개수는 모발진단기로 촬영한 3.6 mm × 2.8 mm 사진으로 모근을 기준으로 하여 모발의 개수를 측정하였으며, 모발 개수의 측정과정은 도 3에 나타내었다.The number of eyebrows was measured in order to investigate the effects of enzyme food and collagen intake on eyebrows of middle - aged women in their 40s and 60s. The number of eyebrows was 3.6 mm × 2.8 mm photographed with a hair diagnosis machine, and the number of hairs was measured based on hair roots. The process of measuring the number of hairs was shown in FIG.
그 결과, 하기 표 4에 나타낸 바와 같이, 눈썹 개수에서 오른쪽과 왼쪽을 함께 보았을 때, Cont.는 사전 평균 10.45개에서 사후 11.33개로 8.32% 증가 경향을, E와 C의 각각 사전 평균 10.96개, 10.46개에서 사후 17.30개, 17.00개로 57.85%, 62.43% 증가를 나타냈다(p<.001, p<.01). EC는 사전 평균 11.91개에서 사후 19.70개로 65.40% 유의한 증가를 나타내(p<.001), Cont.에 비해 EC가 57.08% 더 많아진 것을 확인하였고, E와 C보다는 각각 7.55%, 2.97% 많아진 것을 확인하였다.As a result, as shown in Table 4 below, when the right and left eyebrows were viewed together, Cont. Tended to increase by 8.32% from 10.45 before to 11.33 before, and 10.96, (P <.001, p <.01). The number of postmenopausal dogs increased by 57.85% and 62.43%, respectively. EC was significantly increased from 11.91 to 19.70 (p <.001). The EC was 57.08% higher than Cont. And 7.55% and 2.97% higher than E and C, respectively Respectively.
또한, 양쪽 눈썹 개수의 변화를 각각 보면, Cont.의 오른쪽 눈썹은 사전 평균 10.58개에서 사후 12.16개 14.93% 증가 경향을 보였고, 왼쪽 눈썹은 사전 10.33개에서 사후 10.50개로 1.60% 증가 경향을 보였다. E의 오른쪽 눈썹은 사전 평균 10.69개에서 사후 18.38개로 71.94% 증가하였고(p<.001), 왼쪽 눈썹은 사전 11.23개에서 사후 16.23개로 44.52% 증가했다(p<.01). C의 오른쪽 눈썹은 사전 평균 11.38개에서 사후 18.61개로 63.53% 증가하였고(p<.001), 왼쪽 눈썹은 사전 9.53개에서 사후 15.38개로 61.28% 증가했다(p<.01). EC의 오른쪽 눈썹은 사전 평균 12.75개에서 사후 20.83개로 63.37% 유의하게 증가하였고(p<.001), 왼쪽 눈썹은 사전 11.08개에서 사후 18.58개로 67.68% 유의하게 증가함을 확인하였다(p<.001)(표 4).
In addition, the right eyebrows tended to increase by 12.16 and 14.93%, respectively, from the pre - mean 10.58, and the left eyebrow tended to increase by 1.60% from 10.33 before to 10.50 after. The right eyebrows of E increased 71.94% (p <.001) from 10.69 to 18.38, and the left eyebrows increased 44.22% from 11.23 to 16.23 (p <.01). The right eyebrows of C increased 63.53% (p <.001) from 11.38 to 18.61, and the left eyebrows increased by 61.28% from 9.53 to 15.38. EC right eyebrows increased significantly from an average of 12.75 to 20.83 (63.37%) (p <.001), and that of the left eyebrows increased from 11.08 to 18.58 with 67.68% (p <.001) ) (Table 4).
<2-4> 눈썹의 밀도 변화 확인<2-4> Confirmation of eyebrow density change
본 발명의 효소 식품 및 콜라겐 복합 섭취의 눈썹 밀도에 대한 효과를 확인하기 위하여, 효소 식품과 콜라겐 복합 섭취 전후의 눈썹의 밀도를 간접적으로 볼 수 있는 흡광도 분석을 수행하였다.In order to confirm the effect of the enzyme food and collagen complex intake of the present invention on the eyebrow density, the absorbance analysis was performed to indirectly observe the eyebrow density before and after the enzyme food and collagen composite intake.
그 결과, 하기 표 5에 나타낸 바와 같이, 눈썹의 흡광도에서 오른쪽과 왼쪽을 함께 보았을 때, Cont.는 사전 평균 0.026에서 사후 0.026로 변화가 없고, E와 C는 각각 사전 평균 0.028, 0.028에서 사후 0.022, 0.024로 21.43%, 10.7% 감소경향을 나타냈다. EC는 사전 평균 0.028에서 사후 0.020로 28.57% 유의한 감소를 나타냈다(p<.001). 양쪽 눈썹 흡광도 변화를 각각 보면, Cont.의 오른쪽 눈썹은 사전 평균 0.028에서 사후 0.025로 흡광도의 감소 경향이, 왼쪽 눈썹은 사전 0.024에서 사후 0.027로 흡광도가 증가 경향이 나타났으나, 양쪽 모두에서 유의한 증감을 나타내지 않았다. E의 오른쪽 눈썹은 사전 평균 0.026에서 사후 0.021, 왼쪽 눈썹은 사전 0.029에서 사후 0.023로 각각 19.23%, 20.69%의 흡광도 감소가 나타났으나, 유의한 감소는 아니었다. C의 오른쪽 눈썹은 사전 평균 0.027에서 사후 0.025, 왼쪽 눈썹은 사전 0.028에서 사후 0.024로 각각 7.4%, 14.3%의 흡광도 감소가 나타났으나, 유의한 감소는 보이지 않았다. EC의 오른쪽 눈썹은 사전 평균 0.029에서 사후 0.021로 24.13% 유의한 감소를 나타났다(p<.05). 왼쪽 눈썹은 사전 0.028에서 사후 0.019로 28.57% 유의한 감소를 나타났다(p<.001). 결론적으로, 본 발명의 효소 식품 및 콜라겐 복합 섭취군은 눈썹 양쪽 모두에서 흡광도를 유의적으로 감소시키므로, 눈썹 밀도를 유의적으로 증가시킴을 확인하였고, 이는 효소 식품 및 콜라겐의 상승작용을 통한 결과임을 확인하였다(표 5).
As a result, as shown in Table 5 below, when the right and left sides of the eyebrows were viewed together, Cont. Did not change from 0.026 before to 0.026 after, and E and C were 0.028 before and 0.028 after, respectively , 0.024 to 21.43% and 10.7% respectively. EC significantly decreased 28.57% from pre-mean 0.028 to post-0.020 (p <.001). In both eyebrow absorbance changes, the absorbance of the right eyebrows tended to decrease from 0.028 before to 0.025 after the eyebrows, while the absorbance tended to increase from 0.024 before the eyebrows to 0.027 after the left eyebrows. And did not show any increase or decrease. The right eyebrows of E showed a decrease of 19.23% and 20.69% of absorbance, respectively, from 0.026 before and 0.021 after and 0.029 after, respectively. The right eyebrows of C showed a decrease of 7.4% and 14.3%, respectively, from 0.027 before and 0.025 after, and the left eyebrows from 0.028 before and 0.024 after, respectively, but no significant decrease was observed. EC right eyebrows decreased significantly from pre-mean 0.029 to post-final 0.021 (24.13%) (p <.05). The left eyebrows showed a significant decrease of 28.57% from 0.028 to 0.019 (p <.001). In conclusion, the enzyme food and collagen combination group of the present invention significantly decreased the absorbance at both sides of the eyebrows, thus confirming that the eyebrow density was significantly increased, which is a result of the synergistic action of enzyme food and collagen (Table 5).
<2-5> 눈썹의 짙기 정도 변화 확인<2-5> Confirmation of change of eyebrow depth
효소 식품과 콜라겐 복합 섭취 전후의 눈썹 짙기 변화를 스튜디오에서 촬영하였으며, 그 과정을 도 4에 나타내었다.The change in eyebrow denudation before and after the ingestion of the enzyme food and collagen combination was photographed in the studio, and the process is shown in FIG.
전체적으로 Cont.에 비해 EC의 눈썹이 짙어졌으며, 육안으로는 주로 눈썹 가장자리에서 확연하게 더욱 진해지는 것을 확인할 수 있다. 눈썹의 짙기를 pixel 수를 이용하여 나타내는 방법을 도입하여 눈썹 전체의 짙기를 정량적으로 나타내고자 하였으나, 눈썹이 평면 상태에 있지 않고 곡면 형태로 특히 눈썹 끝 부분이 머리 쪽으로 굽어 있어 눈썹 정면과 곡면부분이 사진상 명암 차가 발생하였다. 이로 인하여 사진에 따라 눈썹의 짙기가 프로그램에서는 조금씩 다르게 해석되고 결과가 일정한 값을 나타내지 못하고 조금씩 error 값을 보였다. 따라서 여러 가지 방법을 시도하여 눈썹을 특정 범위로 좁게 한정하여 분석한 결과는 그 범위 내에서는 눈썹 짙기가 일정하게 같은 값을 나타낼 수 있는 것을 알게 되었다. 따라서 눈썹의 머리쪽은 너무 짙어 육안으로 눈썹 짙기 변화의 판단이 어렵고, 눈썹의 끝쪽에서 1/3 지점 즉 눈썹산 부위가 짙은 정도 변화를 판단하기 쉬워, 이 부분을 실험 전후 눈썹 짙기의 변화 부분으로 선택하여 분석하였고(도. 4b), 하기와 같은 방법으로 눈썹 짙기를 정량적으로 나타내었다.As a whole, EC eyebrows are thicker than Cont., And it can be seen that the naked eye is significantly thicker at the edge of eyebrows. In order to quantify the intensity of eyebrows, we used a method to represent the intensity of eyebrows in terms of pixel counts. However, since the eyebrows are not in a planar state but curved surfaces, especially the ends of the eyebrows are curved toward the head, There was a contrast difference on the photograph. As a result, according to the photographs, the intensity of the eyebrows was interpreted slightly differently in the program, and the result showed a little error value because it did not show a constant value. Therefore, it was found that eyebrow darkness can be constantly the same within the range of narrow range of eyebrows by trying various methods. Therefore, the head of the eyebrows is so thick that it is difficult to judge the change of the eyebrows in the naked eye, and it is easy to judge the degree of change in the degree of darkness at the 1/3 point from the end of the eyebrows. (Fig. 4b) and quantified eyebrow darkness in the following manner.
구체적으로, 눈썹 짙기 분석은 Photoshop CS2 프로그램을 사용하여 실시하였으며 그 방법은 다음과 같다. 우선 원본 사진(도. 4a)의 눈썹부분 중 육안으로 확인 시 실험 전후 변화가 뚜렷한 부분을 rectangular marquee tool을 사용하여 5 × 5 mm 선택하였다(도. 4b). 해당부분을 복사한 뒤 새로 캔버스를 만들어(preset: clipboard) 붙여 넣고 zoom tool(돋보기)를 이용하여 300%로 확대하였다(도. 4c). 전체 pixel 수를 histogram 창(Window-Histogram)에서 확인한 뒤(도. 4d) magic wand tool(Tolerance 32)로 눈썹 모발을 클릭하여 선택한 범위가 눈썹 모양과 일치하면서 histogram 창의 pixels 값이 최고값이 나올 때의 pixel 수(도. 4e)를 구한 뒤 도. 4d에서 확인한 pixel값으로 나눠 해당 부분에서 눈썹이 차지하는 면적비를 구하여 짙은 정도를 비교하였고, 그 결과를 표 6 및 도 5에 나타내었다.Specifically, eyebrow depth analysis was performed using the Photoshop CS2 program. First, when the eyebrows of the original photograph (Fig. 4a) were visually confirmed, a part with a clear change before and after the experiment was selected by using a rectangular marquee tool 5 × 5 mm (Fig. After copying the part, we made a new canvas (preset: clipboard) and enlarged it to 300% by using the zoom tool (Fig. 4c). After checking the total number of pixels in the histogram window (Fig. 4d), click the eyebrow hair with the magic wand tool (Tolerance 32), and the selected range matches the eyebrow shape and the pixels in the histogram window show the highest value (Fig. 4e) of the pixel is obtained. The area ratio occupied by eyebrows was calculated by dividing the value by the pixel value determined in 4d, and the degree of darkness was compared. The results are shown in Table 6 and FIG.
도 5에 나타낸 바와 같이, EC의 눈썹이 효소 식품과 콜라겐식품 식이 후 특히 확연히 짙어진 부분은 화살표로 표시하였다. Cont.의 눈썹 짙기를 살펴보면, 효소 식품과 콜라겐 식품 3개월간 섭취 후 실험 전에 비해 실험 후 평균변화율 3.68%, E와 C의 눈썹 짙기는 사전에 비해 각각 사후 23.37%, 41.29% 짙어진 것으로 나타났으며, 각각 섭취 전에 비해 유의적인 변화를 나타냈다(p<.05). EC의 눈썹 짙기는 사전에 비해 사후 63.22% 짙어진 것으로 나타났으며, 섭취 전에 비해 유의적인 변화를 나타냈다(p<.05). EC가 Cont.보다 59.54% 더 많이 짙어진 것을 확인할 수 있었고, E와 C보다는 각각 39.85%, 21.93% 더 짙어진 것을 확인하였다.As shown in Fig. 5, the eyebrows of the EC were marked with arrows in the areas where the enzyme foods and the collagen foods were particularly darkened after the diet. Contrast enhancement of eyebrows was 3.68% after 3 months of ingestion of enzyme and collagen, 23.37% and 41.29% after E and C, respectively. , Respectively (p <.05). The EC eyebrow heaviness was 63.22% darker than before, and showed significant change compared to before ingestion (p <.05). EC was 59.54% higher than Cont. And 39.85% and 21.93% more than E and C, respectively.
다만, EC가 눈썹의 개수에서 E, C보다 각각 7.55%, 2.97% 증가는 각 군 간에 차이가 적었으나, 눈썹 짙기에서는 EC가 E와 C보다는 각각 39.85%, 21.93% 증가로 짙기의 차가 컸다. 이는 측정부위가 달라서 나타난 것으로 보인다. 즉, 본 실험에서 눈썹의 육모는 주로 눈썹산 부위부터 귀 쪽의 눈썹 끝부분으로 육모가 왕성하여 이 부분이 특히 눈으로도 많은 차이를 보였는데, 이 눈썹산 부분을 눈썹 짙기의 측정부위로 하여 눈썹 개수의 변화보다 더 큰 변화를 보인 것을 확인하였다(도 5).
However, there was little difference in the number of eyebrows between 7.5% and 2.97% in the number of eyebrows compared to E and C, respectively. In the eyebrows, EC was increased by 39.85% and 21.93% than E and C, respectively. This seems to be due to the different measurement sites. In other words, in this experiment, the hair growth of the eyebrows was largely affected by hair growth from the area of the eyebrows to the tip of the eyebrows of the ear, and this part was particularly different from the eyes. (Fig. 5). As shown in Fig.
<2-6> 60대 여성 대상 눈썹의 짙기 정도 변화 확인<2-6> Confirmation of changes in the depth of eyebrows in women in their 60s
60대 여성을 대상으로, 상기 <2-5>와 동일한 방법으로 눈썹의 짙기 정도 변화를 확인하였다.The change in the degree of darkness of the eyebrows was confirmed in the same manner as the above <2-5> for the women in their 60s.
그 결과, 도 6에 나타낸 바와 같이 효소 식품과 콜라겐의 복합 섭취로 실제 눈썹이 나거나 길게 자라게 된 것을 특히 60대에서 두드러짐을 확인하였다. As a result, as shown in FIG. 6, it was confirmed that the eyebrows actually grow or become prolonged due to the combination of enzyme food and collagen, especially in the 60s.
구체적으로 도 6의 섭취 전과 섭취 후의 모습을 화살표로 표기하였다. 도 6의 윗사진은 60대 초반으로 섭취 전 A에서 섭취 후 a로 눈썹산에서 눈썹꼬리부분까지 전체적으로 눈썹이 자랐으며, 눈썹과 눈 사이 부분까지 넓게 자람을 확인하였다. Specifically, the state before and after ingestion of FIG. 6 is indicated by an arrow. In the top photograph of FIG. 6, the eyebrows were grown from the eyebrows to the tail of the eyebrows, and the area between the eyebrows and the eyes was enlarged.
도 6의 아래의 사진은 60대 후반으로 섭취 전 A에서 섭취 후 a로 눈썹머리에서부터 눈썹 꼬리까지 전체적으로 길이가 길게 자라 눈썹의 형태 변화를 볼 수 있다. 이는 효소 식품과 콜라겐의 복합 섭취로 소화 흡수가 용이해져 단백질원의 원활한 공급으로 눈썹도 부분적으로 풍성하게 자라게 된 것을 확인하였다(도 6).
6 shows a change in the shape of the eyebrows after a long period of time from the brow head to the tail of the eyebrow. It was confirmed that complex absorption of enzyme food and collagen facilitated digestion and absorption, and that the eyebrows were partially enriched by smooth supply of protein source (Fig. 6).
<< 실험예Experimental Example 3> 손톱개선 효과 확인 3> Confirm nail improvement effect
<3-1> 손톱의 두께 변화 확인<3-1> Confirmation of change of nail thickness
건강할 때의 정상 손톱은 0.5-0.75 mm의 두께를 가지며(이미선, 2005; 이은영 등, 2009), 헤모글로빈의 주성분인 철분은 신체에서 에너지를 생성하고 공급하는 역할을 하며 철분이 부족하면 손톱이 얇아진다(김광숙 등, 2000).In the case of healthy nails, the normal nail has a thickness of 0.5-0.75 mm (Imyun, 2005; Lee, Eunyoung, 2009). Iron, the main component of hemoglobin, plays a role in generating and supplying energy from the body. (Kim, Kwang-sook et al., 2000).
본 발명에서는 효소 식품 단독, 콜라겐 단독, 효소 식품+콜라겐의 복합식이가 손톱의 개선에 미치는 효과를 알아보기 위해 40-60대 여성을 대상으로 식이 전과 식이 후의 손톱의 두께를 측정하였다. In the present invention, the effect of enzyme food alone, collagen alone, enzyme food + collagen combination on the improvement of nails was measured in pre-diabetic and post-dietary nails of 40-60 years old women.
그 결과 도 7에 나타낸 바와 같이, 식이 전 대조군(Cont.)(p=0.366), 효소 식품(E) 투여군(p=0.268), 콜라겐(C) 투여군, 그리고 효소 식품+콜라겐(EC) 투여군(p=0.242)의 4 그룹 간의 유의적인 차이가 없어 동질성이 검증되었다. 한편, 각각의 효소 식품 단독 또는 콜라겐 단독 및, 효소 식품+콜라겐의 복합식이가 손톱의 개선에 미치는 효과를 알아보기 위하여 손톱 두께의 변화를 보면, Cont.는 식이 전 0.4381 ± 0.0859 mm에서 식이 후 0.4360 ± 0.0894 mm로 0.48%(p=0.983) 감소 경향을, E 투여군은 식이 전 0.5298 ± 0.0513 mm에서 식이 후 0.5654 ± 0.0443 mm로 6.72%(p=0.045) 증가를, C 투여군은 식이 전 0.5732 ± 0.0315 mm에서 식이 후 0.6282 ± 0.0215 mm로 9.60%(p=0.034) 증가를, 본 발명의 EC 투여군은 식이 전 0.4679 ± 0.0420 mm에서 식이 후 0.5432 ± 0.0379 mm로 16.09%(p=0.004) 유의적으로 증가함을 확인하였다(p<0.01).
As a result, as shown in Fig. 7, the control group (p = 0.366), the enzyme food (E) group (p = 0.268), the collagen (C) group and the enzyme food + collagen p = 0.242), the homogeneity was verified. To examine the effect of each enzyme food alone or collagen alone and the combination of enzyme food + collagen on the improvement of fingernails, changes in fingernail thickness were calculated as follows: Cont. = 0.4381 ± 0.0859 mm before dieting, 0.4360 (P = 0.983) in the control group, 0.5724 ± 0.0443 mm in the control group, 0.5724 ± 0.0443 mm in the control group, and 0.72% (p = 0.034) increased to 0.6282 ± 0.0215 mm after the meal, and the EC administration group of the present invention showed a significant increase of 16.09% (p = 0.004) from 0.4679 ± 0.0420 mm before feeding to 0.5432 ± 0.0379 mm after feeding (P < 0.01).
<3-2> 손톱의 밀도 변화 확인<3-2> Confirmation of changes in density of nails
효소 식품 단독 또는 콜라겐 단독, 및 효소 식품+콜라겐의 복합식이가 손톱의 개선에 미치는 효과를 알아보기 위해 40-60대 여성을 대상으로 식이 전과 식이 후의 손톱 시료를 메틸렌블루(methylene blue, MB) 염색법으로 손톱의 밀도를 간접적으로 측정하였다. To investigate the effect of enzyme food alone or collagen alone and enzyme food + collagen combination on the improvement of nails, nail samples of pre- and post-dietary nails were stained with methylene blue (MB) The density of nails was indirectly measured.
구체적으로, 메틸렌블루(methylene blue, MB) 염색법은 일반적으로 세포가 사멸하면 세포의 막이 파괴되어 염색이 되고 세포가 살아있으면 염색이 안 되는 특성을 이용하여 세포 배양 시 세포의 사멸을 측정할 때 사용하는 방법으로, 손톱의 밀도 측정에 이 방법을 응용하기 위하여 식이 전과 식이 후의 손톱 시료에 MB 염색 후 손톱 시료에 흡수된 MB 용액을 다시 추출하여 손톱 밀도의 정도를 측정하였다.Specifically, the methylene blue (MB) staining method is generally used for measuring the cell death upon cell culture using the property that the cell membrane is destroyed and stained when the cell is killed and the staining is not performed when the cell is alive In order to apply this method to the measurement of nail densities, the nail densities were measured by reextracting the MB solution absorbed in the nail samples after MB staining in the nail samples before and after the meal.
그 결과, 도 8에 나타낸 바와 같이, 식이 전 Cont.(p=0.335), E 투여군(p=0.324), C 투여군(p=0.231), 그리고 EC 투여군(p=0.246)의 3 그룹 간의 유의적인 차이는 없어 동질성이 검증되었다. 한편, 효소 식품 단독 또는 콜라겐 단독, 및 효소 식품+콜라겐의 복합식이가 손톱의 개선에 미치는 효과를 알아보기 위하여 손톱의 흡광도의 변화를 보면, Cont. 투여군은 식이 전 0.422 ± 0.042에서 식이 후 0.426 ± 0.016로 0.94%(p=0.786) 증가 경향을, E 투여군은 식이 전 0.410 ± 0.049에서 식이 후 0.394 ± 0.058로 3.90%(p=0.050) 감소를, C 투여군은 식이 전 0.475 ± 0.059에서 식이 후 0.453 ± 0.048로 4.63%(p=0.047) 감소를, 본 발명의 EC 투여군은 식이 전 0.463 ± 0.057에서 식이 후 0.428 ± 0.037로 7.56%(p=0.004) 유의적으로 감소하였다(p<0.01). 즉 MB 염색법을 응용하여 손톱의 밀도를 흡광도변화로 간접적으로 측정해보면 효소 식품+콜라겐군(EC)의 복합식이가 손톱의 밀도를 7.56% 증가시킴을 확인하였다.
As a result, as shown in FIG. 8, there was a significant difference between the three groups of total cont. (P = 0.335), E administration group (p = 0.324), C administration group (p = 0.231) and EC administration group No homogeneity was verified. On the other hand, in order to examine the effects of enzyme food alone or collagen alone and enzyme food + collagen combination on the improvement of nails, (P = 0.786) increased from 0.422 ± 0.042 before dieting to 0.426 ± 0.016 after dieting, and decreased to 0.394 ± 0.058 (p = 0.050) from dietary 0.410 ± 0.049 before dieting to 0.946 C group showed a decrease of 4.63% (p = 0.047) from 0.475 ± 0.059 before feeding to 0.453 ± 0.048 after feeding. The EC administration group of the present invention showed a decrease of 7.56% (p = 0.004) from 0.463 ± 0.057 before feeding to 0.428 ± 0.037 after feeding, (P < 0.01). In other words, by indirectly measuring the density of nails by absorbance change by applying MB staining method, it was confirmed that the complex type of enzyme food + collagen group (EC) increases the density of nails by 7.56%.
Claims (12)
A pharmaceutical composition for preventing and treating eyebrow hair loss comprising rice and soybean enzyme food and collagen as active ingredients.
1) 쌀 및 콩을 침지하는 단계;
2) 상기 단계 1)의 침지된 쌀 및 콩을 증자하는 단계;
3) 상기 증자된 쌀 및 콩에 Aspergillus 속 균주 또는 Bacillus 속 균주를 접종한 후, 배양하는 단계로 제조되는 것을 특징으로 하는 눈썹 탈모 예방 및 치료용 약학적 조성물.
The method according to claim 1,
1) immersing rice and soybeans;
2) growing the immersed rice and soybeans of step 1) above;
3) Inoculating the Aspergillus spp. Or Bacillus spp. Into the above-mentioned rice and soybean and culturing the same, wherein the pharmaceutical composition is for preventing and treating eyebrow hair loss.
[Claim 2] The pharmaceutical composition according to claim 1, wherein the enzyme food and the collagen are mixed at a weight ratio of 1: 0.5 to 2: 1.
The pharmaceutical composition for preventing and treating eyebrow hair loss according to claim 1, wherein the composition promotes eye hair hair growth.
Rice, soybean enzyme food, and collagen as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160046678A KR101827775B1 (en) | 2016-04-18 | 2016-04-18 | Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160046678A KR101827775B1 (en) | 2016-04-18 | 2016-04-18 | Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170117627A Division KR101850770B1 (en) | 2017-09-14 | 2017-09-14 | Composition for improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170119045A KR20170119045A (en) | 2017-10-26 |
KR101827775B1 true KR101827775B1 (en) | 2018-02-09 |
Family
ID=60300852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160046678A KR101827775B1 (en) | 2016-04-18 | 2016-04-18 | Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101827775B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001504510A (en) * | 1996-11-26 | 2001-04-03 | エヌ フワ アン ジュール コセプト,エスアーエルエル ユニペルソネル | Pharmaceutical and cosmetic compositions based on microbial cultures mixed with essential oils and acids |
JP2001321125A (en) | 2000-05-11 | 2001-11-20 | Ichimaru Pharcos Co Ltd | Food and drink for manicure |
JP2005328842A (en) * | 2004-04-22 | 2005-12-02 | Bloodissue Inc | Collagen-enriched functional food |
-
2016
- 2016-04-18 KR KR1020160046678A patent/KR101827775B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001504510A (en) * | 1996-11-26 | 2001-04-03 | エヌ フワ アン ジュール コセプト,エスアーエルエル ユニペルソネル | Pharmaceutical and cosmetic compositions based on microbial cultures mixed with essential oils and acids |
JP2001321125A (en) | 2000-05-11 | 2001-11-20 | Ichimaru Pharcos Co Ltd | Food and drink for manicure |
JP2005328842A (en) * | 2004-04-22 | 2005-12-02 | Bloodissue Inc | Collagen-enriched functional food |
Also Published As
Publication number | Publication date |
---|---|
KR20170119045A (en) | 2017-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5925348A (en) | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin | |
JP3966922B2 (en) | Fibroblast growth promoter | |
CN102188332B (en) | Cosmetic containing oceanic shellfish active peptide and preparation method and application thereof | |
JP6446120B2 (en) | A composition for improving skin containing pomegranate concentrate as an active ingredient | |
JP2016088933A (en) | Age production inhibitor and application thereof | |
TWI500428B (en) | Sugar-free pineapple extract, method for producing the extract, and application of the extract | |
KR101702851B1 (en) | The hair follicle and hair growth promoter composition improved with edible crickets | |
CN101677932A (en) | With the whitening agent of female horse phenols as effective ingredient | |
KR101769419B1 (en) | Multifunctional nourishing cream composition and preparing method of the same | |
JP2012171901A (en) | Food for oral-intake for hair growth of men | |
AU2012344135B2 (en) | Collagen hydrolysate and use thereof | |
KR102358623B1 (en) | Food composition for improving skin condition comprising collagen peptide | |
KR20140107784A (en) | Composition for preventing falling out of the hair and promoting growth of the hair | |
CN106722999B (en) | Collagen peptide preparation method, low-sugar collagen beauty cake containing collagen peptide preparation method and preparation method | |
KR101437997B1 (en) | Fermented caviar extract and its cosmetic usage | |
KR20130003655A (en) | Composition for prevention of hair loss and promotion of hair growth which contains rosa multiflora extract as an active ingredient | |
KR101850770B1 (en) | Composition for improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients | |
JP4703832B2 (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic and food and drink | |
JP5819209B2 (en) | Differentiation promoter from stem cells to brown adipocytes | |
KR20100080991A (en) | Hair cosmetic composition for strengthening hair root | |
KR101827775B1 (en) | Composition for growing of eyebrow and improving of nail and toenail in Menopausal women comprising enzyme food and collagen as active ingredients | |
CN107951737A (en) | Anti-wrinkle anti-allergy eye cream containing stem cell growth factors and preparation method and application thereof | |
JP5828355B1 (en) | Powdered skin external preparation for hair growth / hair growth and skin condition improvement | |
CN112586740A (en) | Protein product and preparation method thereof | |
CN105168067A (en) | Dynamic anti-freckle essence liquid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |